Suppression	O
of	O
c-jun	B-DNA
by	O
antisense	O
oligonucleotides	O
inhibits	O
cell	O
adhesion	O
but	O
not	O
respiratory	O
burst	O
during	O
phorbol	O
ester-induced	O
differentiation	O
of	O
U937	B-cell_line
human	I-cell_line
monoblastic	I-cell_line
cells	I-cell_line
.	O

We	O
studied	O
the	O
role	O
of	O
the	O
immediate	B-DNA
early	I-DNA
gene	I-DNA
c-jun	B-DNA
in	O
cell	O
proliferation	O
and	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
-induced	O
differentiation	O
in	O
U937	B-cell_line
human	I-cell_line
monoblastic	I-cell_line
cells	I-cell_line
,	O
using	O
c-jun	B-DNA
-specific	O
antisense	O
(	O
AS	O
)	O
phosphorothioate	O
oligonucleotides	O
.	O

In	O
selecting	O
the	O
most	O
specific	O
and	O
potent	O
oligonucleotide	O
sequence	O
,	O
we	O
performed	O
extensive	O
analyses	O
for	O
the	O
binding	O
specificity	O
between	O
all	O
candidates	O
of	O
c-jun	B-DNA
AS	O
oligonucleotides	O
and	O
the	O
whole	O
sequences	O
in	O
GenBank	O
database	O
,	O
using	O
a	O
computer	O
program	O
.	O

Among	O
the	O
20	O
selected	O
oligonucleotides	O
,	O
two	O
potent	O
15-mer	O
AS	O
oligonucleotides	O
(	O
C-JUN	O
AS	O
oligonucleotides	O
)	O
exhibited	O
significant	O
inhibition	O
of	O
cell	O
growth	O
in	O
a	O
dose-dependent	O
manner	O
between	O
2	O
and	O
10	O
microM	O
.	O

Reverse	O
transcription-PCR	O
and	O
Western	O
blot	O
analysis	O
demonstrated	O
that	O
10	O
microM	O
of	O
C-JUN	O
AS	O
oligonucleotides	O
reduced	O
c-jun	B-DNA
expression	O
at	O
both	O
the	O
mRNA	B-RNA
and	O
protein	O
levels	O
.	O

More	O
importantly	O
,	O
C-JUN	O
AS	O
oligonucleotides	O
showed	O
distinct	O
effects	O
on	O
two	O
markers	O
of	O
PMA-induced	O
differentiation	O
;	O
the	O
C-JUN	O
AS	O
oligonucleotides	O
inhibited	O
cell	O
adhesion	O
,	O
whereas	O
they	O
did	O
not	O
affect	O
another	O
marker	O
of	O
differentiation	O
,	O
respiratory	O
burst	O
(	O
measured	O
by	O
nitro	O
blue	O
tetrazolium	O
reduction	O
assay	O
)	O
.	O

These	O
results	O
suggest	O
a	O
critical	O
role	O
of	O
c-jun	B-DNA
in	O
both	O
cell	O
proliferation	O
and	O
PMA-induced	O
cell	O
adhesion	O
but	O
not	O
in	O
PMA-induced	O
respiratory	O
burst	O
in	O
U937	B-cell_line
cells	I-cell_line
.	O

Vol	NULL
.	NULL

7	NULL
,	NULL
1005-1012	NULL
,	NULL
August	NULL
1996	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Suppression	NULL
of	NULL
c-jun	NULL
by	NULL
Antisense	NULL
Oligonucleotides	NULL
Inhibits	NULL
Cell	NULL
Adhesion	NULL
but	NULL
not	NULL
Respiratory	NULL
Burst	NULL
during	NULL
Phorbol	NULL
Ester-induced	NULL
Differentiation	NULL
of	NULL
U937	NULL
Human	NULL
Monoblastic	NULL
Cells	NULL
'	NULL
Nobuyoshi	NULL
Momiyama	NULL
,	NULL
Hiroshi	NULL
Shimada	NULL
,	NULL
and	NULL
Masato	NULL
Mitsuhashi	NULL
?	NULL

Second	NULL
Department	NULL
of	NULL
Surgery	NULL
,	NULL
Yokohama	NULL
City	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
3-9	NULL
Fukuura	NULL
,	NULL
Kanazawa-ku	NULL
,	NULL
Yokohama	NULL
236	NULL
,	NULL
Japan	NULL
[	NULL
N.	NULL
M.	NULL
,	NULL
H.	NULL
S.	NULL
]	NULL
,	NULL
and	NULL
Medical	NULL
Science	NULL
Division	NULL
,	NULL
Hitachi	NULL
Chemical	NULL
Research	NULL
Center	NULL
,	NULL
Irvine	NULL
,	NULL
California	NULL
92715	NULL
[	NULL
M.	NULL
M.	NULL
]	NULL
Abstract	NULL
We	NULL
studied	NULL
the	NULL
role	NULL
of	NULL
the	NULL
immediate	NULL
early	NULL
gene	NULL
c-jun	NULL
in	NULL
cell	NULL
proliferation	NULL
and	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
-induced	NULL
differentiation	NULL
in	NULL
U937	NULL
human	NULL
monoblastic	NULL
cells	NULL
,	NULL
using	NULL
c-jun-specific	NULL
antisense	NULL
(	NULL
AS	NULL
)	NULL
phosphorothioate	NULL
oligonucleotides	NULL
.	NULL

In	NULL
selecting	NULL
the	NULL
most	NULL
specific	NULL
and	NULL
potent	NULL
oligonucleotide	NULL
sequence	NULL
,	NULL
we	NULL
performed	NULL
extensive	NULL
analyses	NULL
for	NULL
the	NULL
binding	NULL
specificity	NULL
between	NULL
all	NULL
candidates	NULL
of	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
and	NULL
the	NULL
whole	NULL
sequences	NULL
in	NULL
GenBank	NULL
database	NULL
,	NULL
using	NULL
a	NULL
computer	NULL
program	NULL
.	NULL

Among	NULL
the	NULL
20	NULL
selected	NULL
oligonucleotides	NULL
,	NULL
two	NULL
potent	NULL
15-mer	NULL
AS	NULL
oligonucleotides	NULL
(	NULL
C-JUN	NULL
AS	NULL
oligonucleotides	NULL
)	NULL
exhibited	NULL
significant	NULL
inhibition	NULL
of	NULL
cell	NULL
growth	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
between	NULL
2	NULL
and	NULL
10	NULL
um	NULL
.	NULL

Reverse	NULL
transcription-PCR	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
demonstrated	NULL
that	NULL
10	NULL
um	NULL
of	NULL
C-JUN	NULL
AS	NULL
oligonucleotides	NULL
reduced	NULL
c-jun	NULL
expression	NULL
at	NULL
both	NULL
the	NULL
mRNA	NULL
and	NULL
protein	NULL
levels	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
C-JUN	NULL
AS	NULL
oligonucleotides	NULL
showed	NULL
distinct	NULL
effects	NULL
on	NULL
two	NULL
markers	NULL
of	NULL
PMA-induced	NULL
differentiation	NULL
;	NULL
the	NULL
C-JUN	NULL
AS	NULL
oligonucleotides	NULL
inhibited	NULL
cell	NULL
adhesion	NULL
,	NULL
whereas	NULL
they	NULL
did	NULL
not	NULL
affect	NULL
another	NULL
marker	NULL
of	NULL
differentiation	NULL
,	NULL
respiratory	NULL
burst	NULL
(	NULL
measured	NULL
by	NULL
nitro	NULL
blue	NULL
tetrazolium	NULL
reduction	NULL
assay	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
a	NULL
critical	NULL
role	NULL
of	NULL
c-jun	NULL
in	NULL
both	NULL
cell	NULL
proliferation	NULL
and	NULL
PMA-induced	NULL
cell	NULL
adhesion	NULL
but	NULL
not	NULL
in	NULL
PMA-induced	NULL
respiratory	NULL
burst	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Introduction	NULL
The	NULL
c-jun	NULL
proto-oncogene	NULL
encodes	NULL
a	NULL
leucine	NULL
zipper	NULL
protein	NULL
that	NULL
can	NULL
homodimerize	NULL
or	NULL
heterodimerize	NULL
with	NULL
c-Fos	NULL
protein	NULL
,	NULL
Received	NULL
12/28/95	NULL
;	NULL
revised	NULL
5/2/96	NULL
;	NULL
accepted	NULL
5/28/96	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
Supported	NULL
by	NULL
Hitachi	NULL
Chemical	NULL
Research	NULL
Center	NULL
,	NULL
Inc.	NULL
2	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
,	NULL
at	NULL
Medical	NULL
Science	NULL
Division	NULL
,	NULL
Hitachi	NULL
Chemical	NULL
Research	NULL
Center	NULL
,	NULL
1003	NULL
Health	NULL
Sciences	NULL
Road	NULL
West	NULL
,	NULL
Irvine	NULL
,	NULL
CA	NULL
92715	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
714	NULL
)	NULL
725-2795	NULL
;	NULL
Fax	NULL
:	NULL
(	NULL
714	NULL
)	NULL
725-2727	NULL
;	NULL
E-mail	NULL
:	NULL
masato	NULL
@	NULL
ix.netcom.com	NULL
.	NULL

forming	NULL
the	NULL
nuclear	NULL
complex	NULL
AP-1	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

The	NULL
AP-1	NULL
complex	NULL
can	NULL
function	NULL
as	NULL
a	NULL
transcription	NULL
factor	NULL
through	NULL
binding	NULL
to	NULL
a	NULL
DNA	NULL
consensus	NULL
sequence	NULL
(	NULL
termed	NULL
12-O-tetradecanoylphor-bot-13-acetate-responsive	NULL
elements	NULL
)	NULL
that	NULL
is	NULL
contained	NULL
within	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
many	NULL
cellular	NULL
genes	NULL
such	NULL
as	NULL
colla-genase	NULL
,	NULL
stromelysin	NULL
,	NULL
as	NULL
well	NULL
as	NULL
c-jun	NULL
itself	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
previously	NULL
that	NULL
c-jun	NULL
transcription	NULL
is	NULL
rapidly	NULL
and	NULL
transiently	NULL
activated	NULL
in	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
stimuli	NULL
such	NULL
as	NULL
serum	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
,	NULL
growth	NULL
factors	NULL
(	NULL
8-12	NULL
)	NULL
,	NULL
or	NULL
phorbol	NULL
esters	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
profile	NULL
of	NULL
this	NULL
gene	NULL
expression	NULL
has	NULL
been	NULL
characterized	NULL
as	NULL
IEGs	NULL
,	NULL
°	NULL
including	NULL
c-fos	NULL
and	NULL
c-myc	NULL
(	NULL
14-17	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
IEG	NULL
expression	NULL
does	NULL
not	NULL
require	NULL
intervening	NULL
protein	NULL
syn-thesis	NULL
,	NULL
thus	NULL
IEGs	NULL
are	NULL
thought	NULL
to	NULL
be	NULL
the	NULL
first	NULL
genes	NULL
activated	NULL
after	NULL
mitogenic	NULL
stimuli	NULL
,	NULL
implicating	NULL
that	NULL
these	NULL
genes	NULL
should	NULL
hold	NULL
the	NULL
key	NULL
to	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
of	NULL
complex	NULL
cellular	NULL
proliferation	NULL
and	NULL
differentiation	NULL
cascades	NULL
.	NULL

Furthermore	NULL
,	NULL
inhibition	NULL
of	NULL
c-fos	NULL
expression	NULL
prevents	NULL
3T3	NULL
cell	NULL
proliferation	NULL
in	NULL
both	NULL
quiescent	NULL
and	NULL
logarithmically	NULL
growing	NULL
conditions	NULL
(	NULL
18-20	NULL
)	NULL
,	NULL
suggesting	NULL
the	NULL
essential	NULL
role	NULL
of	NULL
c-fos	NULL
in	NULL
cell	NULL
proliferation	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
also	NULL
shown	NULL
that	NULL
c-myc	NULL
AS	NULL
transcripts	NULL
or	NULL
AS	NULL
oligonucleotides	NULL
inhibit	NULL
cell	NULL
proliferation	NULL
but	NULL
induce	NULL
differentiation	NULL
in	NULL
F-MEL	NULL
and	NULL
HL6O	NULL
cells	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
c-myc	NULL
is	NULL
a	NULL
positive	NULL
regulator	NULL
of	NULL
cell	NULL
proliferation	NULL
but	NULL
a	NULL
negative	NULL
one	NULL
for	NULL
differentiation	NULL
.	NULL

Although	NULL
accumulating	NULL
results	NULL
also	NULL
indicate	NULL
that	NULL
c-jun	NULL
is	NULL
important	NULL
in	NULL
producing	NULL
cell	NULL
proliferation	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
role	NULL
of	NULL
c-jun	NULL
in	NULL
cell	NULL
differentiation	NULL
.	NULL

U937	NULL
human	NULL
monoblastic	NULL
cells	NULL
(	NULL
25	NULL
)	NULL
provide	NULL
a	NULL
model	NULL
system	NULL
for	NULL
the	NULL
study	NULL
of	NULL
c-jun	NULL
in	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

U937	NULL
cells	NULL
can	NULL
be	NULL
differentiated	NULL
into	NULL
macrophage-like	NULL
cells	NULL
by	NULL
PMA	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Within	NULL
24-72	NULL
h	NULL
after	NULL
PMA	NULL
stimulation	NULL
,	NULL
cellular	NULL
characteristics	NULL
are	NULL
switched	NULL
from	NULL
proliferation	NULL
to	NULL
differentiation	NULL
status	NULL
,	NULL
and	NULL
macrophage-like	NULL
functions	NULL
,	NULL
such	NULL
as	NULL
cellular	NULL
adherence	NULL
to	NULL
plastic	NULL
plates	NULL
and	NULL
phagocyte	NULL
respiratory	NULL
burst	NULL
,	NULL
are	NULL
clearly	NULL
induced	NULL
.	NULL

Numerous	NULL
reports	NULL
have	NULL
shown	NULL
that	NULL
these	NULL
functional	NULL
maturations	NULL
with	NULL
proliferation	NULL
arrest	NULL
were	NULL
preceded	NULL
by	NULL
a	NULL
rapid	NULL
increase	NULL
in	NULL
c-Jun	NULL
protein	NULL
levels	NULL
(	NULL
27-30	NULL
)	NULL
,	NULL
however	NULL
,	NULL
it	NULL
is	NULL
somewhat	NULL
paradoxical	NULL
because	NULL
a	NULL
similar	NULL
up-regulation	NULL
of	NULL
c-Jun	NULL
is	NULL
noted	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
U937	NULL
cell	NULL
proliferation	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
fundamental	NULL
question	NULL
of	NULL
whether	NULL
PMA-induced	NULL
c-jun	NULL
expression	NULL
is	NULL
a	NULL
°	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IEG	NULL
,	NULL
immediate	NULL
early	NULL
gene	NULL
;	NULL
AS	NULL
,	NULL
antisense	NULL
;	NULL
NBT	NULL
,	NULL
nitro	NULL
blue	NULL
tetrazolium	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
Tm	NULL
,	NULL
melting	NULL
temperature	NULL
;	NULL
ATF	NULL
;	NULL
activating	NULL
transcription	NULL
factor	NULL
;	NULL
MAP	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
;	NULL
RT-PCR	NULL
,	NULL
reverse	NULL
transcription-PCR	NULL
;	NULL
FBS	NULL
,	NULL
fetal	NULL
bovine	NULL
serum	NULL
;	NULL
TBS	NULL
,	NULL
Tris-buffered	NULL
saline	NULL
.	NULL

1006	NULL
_	NULL
Role	NULL
of	NULL
c-jun	NULL
in	NULL
Hematopoietic	NULL
Cell	NULL
Differentiation	NULL
Table	NULL
1	NULL
Oligonucleotide	NULL
sequences	NULL
Oligo	NULL
#	NULL
-	NULL
Position	NULL
``	NULL
-	NULL
Length	NULL
(	NULL
mer	NULL
)	NULL
Tm	NULL
``	NULL
Sequence	NULL
(	NULL
5	NULL
'	NULL
to	NULL
3°	NULL
)	NULL
1	NULL
1047	NULL
15	NULL
30.3	NULL
TAATTAAGATGCCTC	NULL
2	NULL
1047	NULL
17	NULL
35.9	NULL
GTTAATTAAGATGCCTC	NULL
3	NULL
1047	NULL
18	NULL
41.2	NULL
GGTTAATTAAGATGCCTC	NULL
4	NULL
1046	NULL
20	NULL
50	NULL
GCGTTAATTAAGATGCCTCC	NULL
5	NULL
1022	NULL
20	NULL
51.9	NULL
crertractrercceacrcece	NULL
6	NULL
1253	NULL
15	NULL
33.5	NULL
CAGTCATAGAACAGT	NULL
7	NULL
1252	NULL
16	NULL
37.5	NULL
-	NULL
CAGTCATAGAACAGTC	NULL
8	NULL
1252	NULL
17	NULL
43.3	NULL
-	NULL
GCAGTCATAGAACAGTC	NULL
9	NULL
1251	NULL
18	NULL
47.7	NULL
-	NULL
GCAGTCATAGAACAGTCC	NULL
10	NULL
1240	NULL
20	NULL
52.7	NULL
GAACAGTCCGTCACTTCACG	NULL
11	NULL
2197	NULL
15	NULL
33.2	NULL
GTTAACGTGGTTCAT	NULL
12	NULL
2198	NULL
16	NULL
38.3	NULL
CTGTTAACGTGGTTCA	NULL
13	NULL
2196	NULL
18	NULL
42.4	NULL
-	NULL
CTGTTAACGTGGTTCATG	NULL
14	NULL
2194	NULL
20	NULL
47.8	NULL
-	NULL
CTGTTAACGTGGTTCATGAC	NULL
15	NULL
2215	NULL
20	NULL
55.7	NULL
GTTAGCATGAGTTGGCACCC	NULL
16	NULL
3207	NULL
15	NULL
33.3	NULL
CCATATAGATACGCT	NULL
17	NULL
3228	NULL
16	NULL
39.8	NULL
CACTAGCCTTTGGTAA	NULL
18	NULL
3205	NULL
17	NULL
42.4	NULL
-	NULL
CCATATAGATACGCTGG	NULL
19	NULL
3220	NULL
19	NULL
49.2	NULL
GCCTTTGGTAAGCAATTCC	NULL
20	NULL
3226	NULL
20	NULL
55.1	NULL
CGCACTAGCCTTTGGTAAGC	NULL
Control	NULL
-	NULL
15	NULL
-	NULL
_	NULL
CTGAAGTGGCATGAG	NULL
``	NULL
Starting	NULL
position	NULL
of	NULL
target	NULL
sequences	NULL
within	NULL
the	NULL
c-jun	NULL
cDNA	NULL
(	NULL
HUMJUNA	NULL
}	NULL
.	NULL

®	NULL
Nearest	NULL
neighbor	NULL
calculations	NULL
of	NULL
Tm	NULL
for	NULL
DNA	NULL
:	NULL
DNA	NULL
.	NULL

mainspring	NULL
or	NULL
a	NULL
byproduct	NULL
during	NULL
differentiation	NULL
of	NULL
U937	NULL
cells	NULL
remains	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
designed	NULL
a	NULL
series	NULL
of	NULL
c-jun-specific	NULL
AS	NULL
phosphorothioate	NULL
oligonucleotides	NULL
and	NULL
then	NULL
evaluated	NULL
their	NULL
effects	NULL
on	NULL
U937	NULL
cell	NULL
proliferation	NULL
.	NULL

Using	NULL
the	NULL
most	NULL
specific	NULL
and	NULL
potent	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
possible	NULL
effect	NULL
of	NULL
the	NULL
oligonucleotides	NULL
on	NULL
PMA-induced	NULL
functional	NULL
maturation	NULL
.	NULL

The	NULL
present	NULL
study	NULL
demonstrates	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
c-Jun	NULL
protein	NULL
expression	NULL
significantly	NULL
reduces	NULL
cell	NULL
proliferation	NULL
and	NULL
PMA-induced	NULL
adherent	NULL
activity	NULL
but	NULL
not	NULL
PMA-induced	NULL
respiratory	NULL
burst	NULL
measured	NULL
by	NULL
NBT	NULL
reduction	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
a	NULL
critical	NULL
role	NULL
of	NULL
c-jun	NULL
in	NULL
cell	NULL
proliferation	NULL
and	NULL
PMA-induced	NULL
cell	NULL
adhesion	NULL
but	NULL
not	NULL
in	NULL
PMA-induced	NULL
respiratory	NULL
burst	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Results	NULL
Sequence	NULL
of	NULL
Oligonucleotides	NULL
.	NULL

The	NULL
sequence	NULL
,	NULL
length	NULL
,	NULL
and	NULL
nearest	NULL
neighbor	NULL
calculations	NULL
of	NULL
the	NULL
Tm	NULL
of	NULL
each	NULL
oligonucleotide	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

In	NULL
designing	NULL
the	NULL
AS	NULL
sequence	NULL
,	NULL
we	NULL
first	NULL
assigned	NULL
the	NULL
Tm	NULL
of	NULL
oligonucleotides	NULL
as	NULL
35	NULL
,	NULL
40	NULL
,	NULL
45	NULL
,	NULL
50	NULL
,	NULL
and	NULL
55°C	NULL
.	NULL

All	NULL
possible	NULL
sequences	NULL
that	NULL
would	NULL
have	NULL
the	NULL
given	NULL
Tms	NULL
were	NULL
extracted	NULL
from	NULL
every	NULL
position	NULL
of	NULL
the	NULL
c-jun	NULL
mRNA	NULL
,	NULL
then	NULL
the	NULL
specificity	NULL
(	NULL
the	NULL
degree	NULL
of	NULL
cross-hybridization	NULL
against	NULL
the	NULL
whole	NULL
sequences	NULL
in	NULL
the	NULL
GenBank	NULL
database	NULL
)	NULL
of	NULL
each	NULL
oligonucleotide	NULL
,	NULL
and	NULL
the	NULL
possibility	NULL
of	NULL
forming	NULL
a	NULL
secondary	NULL
structure	NULL
in	NULL
both	NULL
oligonucleotides	NULL
and	NULL
the	NULL
target	NULL
mRNA	NULL
was	NULL
analyzed	NULL
by	NULL
a	NULL
computer	NULL
program	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Twenty	NULL
candidates	NULL
of	NULL
sequences	NULL
were	NULL
chosen	NULL
from	NULL
four	NULL
different	NULL
sites	NULL
on	NULL
the	NULL
c-jun	NULL
mRNA	NULL
such	NULL
as	NULL
:	NULL
(	NULL
a	NULL
)	NULL
5'-untranslated	NULL
region	NULL
(	NULL
position	NULL
1022-1047	NULL
)	NULL
;	NULL
(	NULL
b	NULL
)	NULL
AUG	NULL
translation	NULL
initiation	NULL
codon	NULL
(	NULL
position	NULL
1261-1263	NULL
)	NULL
;	NULL
(	NULL
c	NULL
)	NULL
coding	NULL
-	NULL
region	NULL
-	NULL
(	NULL
position	NULL
2194-2215	NULL
)	NULL
,	NULL
and	NULL
(	NULL
d	NULL
)	NULL
3'-untranslated	NULL
region	NULL
(	NULL
position	NULL
3205-3228	NULL
)	NULL
.	NULL

The	NULL
selected	NULL
20	NULL
sequences	NULL
exhibited	NULL
maximum	NULL
specificity	NULL
against	NULL
other	NULL
members	NULL
of	NULL
the	NULL
jun	NULL
gene	NULL
family	NULL
,	NULL
junB	NULL
and	NULL
70	NULL
#	NULL
5	NULL
8	NULL
-	NULL
so	NULL
sel	NULL
O	NULL
-	NULL
--	NULL
50	NULL
X	NULL
L	NULL
a	NULL
$	NULL
-	NULL
«	NULL
C	NULL
a	NULL
|	NULL
3	NULL
30	NULL
@	NULL
|	NULL
|	NULL
C	NULL
|	NULL
|	NULL
G	NULL
-	NULL
201	NULL
|	NULL
|	NULL
€	NULL
|	NULL
E	NULL
10	NULL
4	NULL
|	NULL
|	NULL
*2	NULL
|	NULL
|	NULL
|	NULL
&	NULL
o	NULL
.i	NULL
|	NULL
|	NULL
|	NULL
U	NULL
C	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
91011121314151617181920	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Effect	NULL
of	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
on	NULL
U937	NULL
cell	NULL
profiferation	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
seeded	NULL
in	NULL
96-well	NULL
plates	NULL
at	NULL
a	NULL
density	NULL
of	NULL
2500	NULL
cells/well	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
RPMI	NULL
1640	NULL
with	NULL
0.5	NULL
%	NULL
FBS	NULL
,	NULL
and	NULL
10	NULL
um	NULL
of	NULL
oligonucleotide	NULL
were	NULL
added	NULL
.	NULL

After	NULL
a	NULL
24-h	NULL
incubation	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
U	NULL
,	NULL
untreated	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
either	NULL
control	NULL
(	NULL
C	NULL
)	NULL
or	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
(	NULL
7-20	NULL
)	NULL
,	NULL
serum	NULL
concentration	NULL
was	NULL
adjusted	NULL
to	NULL
10	NULL
%	NULL
,	NULL
and	NULL
culture	NULL
was	NULL
continued	NULL
for	NULL
an	NULL
additional	NULL
2	NULL
days	NULL
without	NULL
removing	NULL
the	NULL
oligonucleotides	NULL
.	NULL

Cells	NULL
were	NULL
exposed	NULL
to	NULL
0.5	NULL
uCi/well	NULL
of	NULL
PH|thymidine	NULL
for	NULL
the	NULL
last	NULL
6	NULL
h	NULL
,	NULL
then	NULL
cellular	NULL
uptake	NULL
of	NULL
midine	NULL
was	NULL
counted	NULL
.	NULL

Values	NULL
are	NULL
the	NULL
mean	NULL
*	NULL
SD	NULL
of	NULL
triplicate	NULL
wells	NULL
.	NULL

c-jun	NULL
AS	NULL
oligonucleotides	NULL
were	NULL
targeted	NULL
for	NULL
5'-untransiated	NULL
region	NULL
(	NULL
7-5	NULL
)	NULL
,	NULL
AUG	NULL
translation	NULL
initiation	NULL
region	NULL
(	NULL
6-10	NULL
)	NULL
,	NULL
coding	NULL
region	NULL
(	NULL
17-75	NULL
)	NULL
,	NULL
and	NULL
3'-untranslated	NULL
region	NULL
(	NULL
16-20	NULL
)	NULL
.	NULL

The	NULL
Tm	NULL
of	NULL
each	NULL
oligonucleotide	NULL
was	NULL
approximately	NULL
35°C	NULL
(	NULL
1	NULL
,	NULL
6	NULL
,	NULL
11	NULL
,	NULL
and	NULL
16	NULL
)	NULL
,	NULL
40°C	NULL
(	NULL
2	NULL
,	NULL
7	NULL
,	NULL
12	NULL
,	NULL
and	NULL
17	NULL
)	NULL
,	NULL
45°C	NULL
(	NULL
3	NULL
,	NULL
8	NULL
,	NULL
13	NULL
,	NULL
and	NULL
18	NULL
)	NULL
,	NULL
50°C	NULL
(	NULL
4	NULL
,	NULL
9	NULL
,	NULL
14	NULL
,	NULL
and	NULL
19	NULL
)	NULL
,	NULL
or	NULL
55°C	NULL
(	NULL
5	NULL
,	NULL
10	NULL
,	NULL
15	NULL
,	NULL
and	NULL
20	NULL
)	NULL
.	NULL

junD	NULL
,	NULL
with	NULL
additional	NULL
specificity	NULL
against	NULL
the	NULL
primate	NULL
database	NULL
in	NULL
GenBank	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
15-mer	NULL
oligonucleotides	NULL
that	NULL
have	NULL
the	NULL
5'-CTGAAGTGGCATGAG-3	NULL
'	NULL
sequence	NULL
were	NULL
used	NULL
.	NULL

Effect	NULL
of	NULL
c-jun	NULL
AS	NULL
Oligonucleotides	NULL
on	NULL
U937	NULL
Cell	NULL
Proliferation	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
20	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
on	NULL
U937	NULL
cell	NULL
proliferation	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
um	NULL
of	NULL
each	NULL
oligonucleotide	NULL
,	NULL
and	NULL
the	NULL
cell	NULL
proliferation	NULL
rate	NULL
was	NULL
determined	NULL
by	NULL
[	NULL
®H	NULL
]	NULL
thymidine	NULL
pulse	NULL
assay	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
at	NULL
48	NULL
h	NULL
after	NULL
oligonucleotide	NULL
treatment	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
20	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
(	NULL
1-20	NULL
)	NULL
revealed	NULL
several	NULL
degrees	NULL
of	NULL
inhibitory	NULL
effects	NULL
on	NULL
U937	NULL
cell	NULL
proliferation	NULL
compared	NULL
to	NULL
untreated	NULL
cells	NULL
(	NULL
U	NULL
)	NULL
.	NULL

Three	NULL
of	NULL
the	NULL
four	NULL
oligonucleotides	NULL
with	NULL
Tm	NULL
35°C	NULL
(	NULL
6	NULL
,	NULL
11	NULL
,	NULL
and	NULL
16	NULL
)	NULL
revealed	NULL
higher	NULL
inhibition	NULL
(	NULL
ranging	NULL
between	NULL
76	NULL
and	NULL
83	NULL
%	NULL
)	NULL
,	NULL
whereas	NULL
four	NULL
oligonucleotides	NULL
with	NULL
Tm	NULL
55°C	NULL
(	NULL
5	NULL
,	NULL
10	NULL
,	NULL
15	NULL
,	NULL
and	NULL
20	NULL
)	NULL
showed	NULL
less	NULL
inhibition	NULL
(	NULL
ranging	NULL
between	NULL
24	NULL
and	NULL
27	NULL
%	NULL
)	NULL
,	NULL
similar	NULL
to	NULL
that	NULL
shown	NULL
by	NULL
the	NULL
control	NULL
oligonucleotide	NULL
(	NULL
C	NULL
;	NULL
28	NULL
%	NULL
)	NULL
.	NULL

The	NULL
inhibitory	NULL
rates	NULL
of	NULL
other	NULL
oligonucleotides	NULL
with	NULL
Tms	NULL
40	NULL
,	NULL
45	NULL
,	NULL
and	NULL
50°C	NULL
ranged	NULL
between	NULL
22	NULL
%	NULL
and	NULL
63	NULL
%	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
consistently	NULL
observed	NULL
with	NULL
three	NULL
different	NULL
batches	NULL
of	NULL
each	NULL
oligonu-cleotide	NULL
.	NULL

(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
AS-1	NULL
(	NULL
6	NULL
)	NULL
and	NULL
AS-2	NULL
(	NULL
11	NULL
)	NULL
were	NULL
used	NULL
for	NULL
subsequent	NULL
analyses	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
either	NULL
AS-1	NULL
or	NULL
control	NULL
oligonucleotide	NULL
,	NULL
and	NULL
the	NULL
cell	NULL
proliferation	NULL
rate	NULL
was	NULL
determined	NULL
every	NULL
24	NULL
h	NULL
by	NULL
[	NULL
°HJthymidine	NULL
uptake	NULL
.	NULL

Cells	NULL
treated	NULL
with	NULL
buffer	NULL
alone	NULL
or	NULL
10	NULL
um	NULL
of	NULL
control	NULL
oligonucleotide	NULL
revealed	NULL
logarithmic	NULL
cell	NULL
growth	NULL
for	NULL
3	NULL
days	NULL
after	NULL
treatment	NULL
,	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
lil	NULL
95	NULL
E	NULL
a	NULL
O	NULL
&	NULL
xX	NULL
104	NULL
o	NULL
SC	NULL
&	NULL
©	NULL
S	NULL
<	NULL
4	NULL
13	NULL
a	NULL
J	NULL
€	NULL
°	NULL
C	NULL
E	NULL
,	NULL
€	NULL
F	NULL
T	NULL
0	NULL
T	NULL
T	NULL
T	NULL
®	NULL
0	NULL
1	NULL
2	NULL
3	NULL
Day	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Dose-dependent	NULL
effect	NULL
of	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
on	NULL
U937	NULL
cell	NULL
profiferation	NULL
.	NULL

U937	NULL
cells	NULL
(	NULL
2	NULL
,	NULL
500	NULL
cells/well	NULL
)	NULL
were	NULL
treated	NULL
without	NULL
(	NULL
0	NULL
)	NULL
or	NULL
with	NULL
10	NULL
um	NULL
of	NULL
control	NULL
oligonucleotide	NULL
(	NULL
@	NULL
)	NULL
or	NULL
various	NULL
concentrations	NULL
(	NULL
2	NULL
(	NULL
0	NULL
)	NULL
,	NULL
5	NULL
(	NULL
@	NULL
or	NULL
10	NULL
(	NULL
A	NULL
)	NULL
uw	NULL
)	NULL
of	NULL
c-jun	NULL
AS	NULL
oligonucteotide	NULL
AS-1	NULL
,	NULL
and	NULL
cellular	NULL
uptake	NULL
of	NULL
PHIthymidine	NULL
was	NULL
counted	NULL
daily	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Values	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplicate	NULL
wells	NULL
.	NULL

whereas	NULL
AS-1	NULL
consistently	NULL
inhibited	NULL
cell	NULL
proliferation	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
between	NULL
2	NULL
and	NULL
10	NULL
um	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Although	NULL
2	NULL
um	NULL
of	NULL
AS-1	NULL
revealed	NULL
sufficient	NULL
inhibition	NULL
of	NULL
cell	NULL
proliferation	NULL
for	NULL
up	NULL
to	NULL
2	NULL
days	NULL
,	NULL
cells	NULL
started	NULL
to	NULL
proliferate	NULL
after	NULL
day	NULL
2	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
10	NULL
um	NULL
of	NULL
AS-1	NULL
induced	NULL
stronger	NULL
inhibition	NULL
,	NULL
and	NULL
its	NULL
effect	NULL
lasted	NULL
for	NULL
at	NULL
least	NULL
3	NULL
days	NULL
after	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
inhibitory	NULL
effects	NULL
of	NULL
AS	NULL
oligonucleotides	NULL
on	NULL
U937	NULL
cell	NULL
growth	NULL
were	NULL
further	NULL
confirmed	NULL
by	NULL
counting	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
10	NULL
um	NULL
of	NULL
AS-1	NULL
consistently	NULL
and	NULL
significantly	NULL
inhibited	NULL
cell	NULL
growth	NULL
for	NULL
at	NULL
least	NULL
4	NULL
days	NULL
after	NULL
treatment	NULL
,	NULL
whereas	NULL
the	NULL
number	NULL
of	NULL
untreated	NULL
cells	NULL
and	NULL
control	NULL
oligonucleotide-treated	NULL
cells	NULL
increased	NULL
within	NULL
this	NULL
period	NULL
of	NULL
time	NULL
{	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
routinely	NULL
confirmed	NULL
by	NULL
trypan	NULL
blue	NULL
dye	NULL
exclusion	NULL
,	NULL
and	NULL
it	NULL
was	NULL
always	NULL
more	NULL
than	NULL
90	NULL
%	NULL
throughout	NULL
the	NULL
experiments	NULL
.	NULL

Unlike	NULL
the	NULL
previous	NULL
report	NULL
by	NULL
Holt	NULL
et	NULL
a/	NULL
.	NULL

(	NULL
22	NULL
)	NULL
,	NULL
in	NULL
which	NULL
c-myc	NULL
AS	NULL
oligonucleotides	NULL
inhibited	NULL
cell	NULL
growth	NULL
and	NULL
induced	NULL
cellular	NULL
differentiation	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
cell	NULL
growth	NULL
by	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
AS-1	NULL
and	NULL
AS-2	NULL
was	NULL
not	NULL
accompanied	NULL
by	NULL
terminal	NULL
differentiation	NULL
in	NULL
U937	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Kinetics	NULL
of	NULL
PMA-induced	NULL
c-Jun	NULL
Protein	NULL
Expression	NULL
in	NULL
U937	NULL
Cells	NULL
.	NULL

U937	NULL
cells	NULL
can	NULL
be	NULL
differentiated	NULL
along	NULL
with	NULL
the	NULL
monocyte-macrophage	NULL
pathway	NULL
by	NULL
PMA	NULL
stimulation	NULL
,	NULL
and	NULL
this	NULL
phenotypic	NULL
alteration	NULL
is	NULL
preceded	NULL
by	NULL
c-jun	NULL
up-regulation	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
kinetics	NULL
of	NULL
c-Jun	NULL
protein	NULL
expression	NULL
after	NULL
exposure	NULL
to	NULL
PMA	NULL
.	NULL

Total	NULL
cellular	NULL
protein	NULL
was	NULL
extracted	NULL
before	NULL
and	NULL
after	NULL
treatment	NULL
with	NULL
PMA	NULL
and	NULL
was	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

The	NULL
results	NULL
(	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
demonstrated	NULL
that	NULL
lower	NULL
levels	NULL
of	NULL
c-Jun	NULL
protein	NULL
were	NULL
expressed	NULL
in	NULL
U937	NULL
cells	NULL
while	NULL
in	NULL
an	NULL
unstimulated	NULL
condition	NULL
,	NULL
but	NULL
a	NULL
rapid	NULL
increase	NULL
(	NULL
12-fold	NULL
)	NULL
in	NULL
c-Jun	NULL
protein	NULL
expression	NULL
was	NULL
induced	NULL
within	NULL
1	NULL
h	NULL
after	NULL
PMA	NULL
treatment	NULL
.	NULL

However	NULL
,	NULL
this	NULL
induction	NULL
was	NULL
transient	NULL
and	NULL
decreased	NULL
by	NULL
half	NULL
at	NULL
3	NULL
h	NULL
after	NULL
PMA	NULL
treatment	NULL
.	NULL

Effect	NULL
of	NULL
c-jun	NULL
AS	NULL
Oligonucleotides	NULL
on	NULL
PMA-induced	NULL
c-Jun	NULL
Protein	NULL
Expression	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
effect	NULL
of	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
on	NULL
protein	NULL
expression	NULL
,	NULL
U937	NULL
cells	NULL
initially	NULL
300	NULL
~	NULL
200	NULL
~I	NULL
cells	NULL
1x	NULL
104	NULL
/	NULL
ml	NULL
100	NULL
-	NULL
]	NULL
0	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Day	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
c-jun	NULL
AS	NULL
oligonucieotides	NULL
on	NULL
cell	NULL
number	NULL
.	NULL

U937	NULL
cells	NULL
(	NULL
2	NULL
,	NULL
500	NULL
cells/well	NULL
)	NULL
were	NULL
treated	NULL
without	NULL
(	NULL
C	NULL
)	NULL
or	NULL
with	NULL
10	NULL
um	NULL
of	NULL
either	NULL
control	NULL
(	NULL
@	NULL
)	NULL
or	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
(	NULL
L	NULL
)	NULL
)	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Viable	NULL
cell	NULL
number	NULL
was	NULL
counted	NULL
daily	NULL
by	NULL
trypan	NULL
blue	NULL
dye	NULL
exclusion	NULL
method	NULL
.	NULL

Values	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplicate	NULL
wells	NULL
.	NULL

vs	NULL
1	NULL
o	NULL
m	NULL
3	NULL
L	NULL
relative	NULL
intensity	NULL
0	NULL
30°	NULL
th	NULL
2h	NULL
3h	NULL
PMA	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

-	NULL
Kinetics	NULL
of	NULL
PMA-induced	NULL
c-Jun	NULL
protein	NULL
expression	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
in	NULL
U937	NULL
cells	NULL
after	NULL
treatment	NULL
with	NULL
160	NULL
nm	NULL
PMA	NULL
.	NULL

Total	NULL
cellular	NULL
protein	NULL
was	NULL
extracted	NULL
at	NULL
several	NULL
time	NULL
intervals	NULL
as	NULL
indicated	NULL
.	NULL

Twenty	NULL
ug	NULL
of	NULL
total	NULL
protein	NULL
were	NULL
electrophoresed	NULL
,	NULL
blotted	NULL
onto	NULL
nitrocellulose	NULL
membranes	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
a	NULL
rabbit	NULL
anti-human	NULL
c-Jun	NULL
antibody	NULL
followed	NULL
by	NULL
alkaline	NULL
phosphatase-based	NULL
color	NULL
develop-ment	NULL
.	NULL

Band	NULL
intensity	NULL
was	NULL
measured	NULL
by	NULL
a	NULL
densitometer	NULL
(	NULL
fop	NULL
)	NULL
.	NULL

treated	NULL
with	NULL
or	NULL
without	NULL
either	NULL
control	NULL
or	NULL
AS	NULL
oligonucleotide	NULL
(	NULL
AS-1	NULL
)	NULL
were	NULL
exposed	NULL
to	NULL
PMA	NULL
,	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
.	NULL

Significant	NULL
suppression	NULL
of	NULL
PMA-induced	NULL
c-Jun	NULL
protein	NULL
expression	NULL
was	NULL
observed	NULL
only	NULL
after	NULL
AS	NULL
treatment	NULL
,	NULL
whereas	NULL
no	NULL
inhibitory	NULL
effect	NULL
was	NULL
detected	NULL
on	NULL
-actin	NULL
protein	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
consistently	NULL
observed	NULL
with	NULL
three	NULL
different	NULL
experiments	NULL
,	NULL
and	NULL
the	NULL
densito-metrical	NULL
analysis	NULL
showed	NULL
it	NULL
was	NULL
statistically	NULL
significant	NULL
(	NULL
P	NULL
<	NULL
0.01	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
c-jun	NULL
AS	NULL
Oligonucleotides	NULL
on	NULL
c-jun	NULL
mRNA	NULL
Expression	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
AS	NULL
oligonucleotides	NULL
on	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
,	NULL
U937	NULL
cells	NULL
initially	NULL
treated	NULL
with	NULL
or	NULL
1007	NULL
1008	NULL
-	NULL
Role	NULL
of	NULL
c-jun	NULL
in	NULL
Hematopoietic	NULL
Cell	NULL
Differentiation	NULL
1.5	NULL
-	NULL
*p	NULL
<	NULL
0.01	NULL
os	NULL
4	NULL
~	NULL
$	NULL
0.0	NULL
T	NULL
¥	NULL
relative	NULL
intensity	NULL
LFA	NULL
c-jun	NULL
s-	NULL
actin	NULL
1	NULL
2	NULL
3	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
c-jun	NULL
AS	NULL
oligonucteotides	NULL
on	NULL
PMA-induced	NULL
c-Jun	NULL
protein	NULL
expression	NULL
.	NULL

Cells	NULL
treated	NULL
without	NULL
(	NULL
Lane	NULL
1	NULL
)	NULL
or	NULL
with	NULL
either	NULL
10	NULL
um	NULL
of	NULL
control	NULL
(	NULL
Lane	NULL
2	NULL
)	NULL
or	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
(	NULL
Lane	NULL
3	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
160	NULL
nu	NULL
PMA	NULL
.	NULL

Total	NULL
cellular	NULL
protein	NULL
was	NULL
extracted	NULL
,	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
1	NULL
h	NULL
after	NULL
PMA	NULL
stimulation	NULL
.	NULL

Twenty	NULL
ug	NULL
of	NULL
total	NULL
protein	NULL
were	NULL
electrophoresed	NULL
,	NULL
blotted	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
an	NULL
anti-human	NULL
c-Jun	NULL
or	NULL
an	NULL
anti-human	NULL
Actin	NULL
antibody	NULL
.	NULL

Band	NULL
intensity	NULL
was	NULL
measured	NULL
by	NULL
a	NULL
densitometer	NULL
(	NULL
fop	NULL
)	NULL
.	NULL

Values	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
in	NULL
triplicate	NULL
.	NULL
'	NULL

,	NULL
P	NULL
<	NULL
0.01	NULL
,	NULL
compared	NULL
to	NULL
the	NULL
values	NULL
of	NULL
control	NULL
oligonucieotide-	NULL
and	NULL
C-JUN	NULL
AS-treated	NULL
cells	NULL
by	NULL
unpaired	NULL
Student	NULL
's	NULL
t	NULL
test	NULL
.	NULL

PMA	NULL
Serum	NULL
AS	NULL
(	NULL
-	NULL
)	NULL
AS	NULL
(	NULL
+	NULL
)	NULL
_	NULL
AS	NULL
(	NULL
-	NULL
)	NULL
AS	NULL
(	NULL
+	NULL
)	NULL
0	NULL
th	NULL
0	NULL
h	NULL
_	NULL
_0	NULL
th	NULL
0	NULL
t	NULL
-526b.p	NULL
.	NULL

B	NULL
-actin	NULL
I	NULL
I	NULL
l	NULL
-	NULL
#	NULL
322b.p	NULL
.	NULL

Fig	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
on	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
.	NULL

Cells	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
10	NULL
um	NULL
of	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
were	NULL
exposed	NULL
to	NULL
either	NULL
PMA	NULL
(	NULL
final	NULL
concentration	NULL
160	NULL
nm	NULL
)	NULL
or	NULL
serum	NULL
(	NULL
final	NULL
concentration	NULL
10	NULL
%	NULL
)	NULL
.	NULL

Total	NULL
mRNA	NULL
was	NULL
extracted	NULL
from	NULL
1	NULL
x	NULL
10°	NULL
cells	NULL
by	NULL
a	NULL
procedure	NULL
using	NULL
biotinylated	NULL
oligo-deoxythymidine	NULL
and	NULL
streptavidine	NULL
paramagnetic	NULL
particles	NULL
1	NULL
h	NULL
after	NULL
each	NULL
stimulation	NULL
.	NULL

RT-PCR	NULL
was	NULL
performed	NULL
using	NULL
c-jun-specific	NULL
primer	NULL
pairs	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
electrophoresed	NULL
on	NULL
1.2	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
followed	NULL
by	NULL
staining	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

without	NULL
10	NULL
um	NULL
of	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
were	NULL
exposed	NULL
to	NULL
either	NULL
PMA	NULL
or	NULL
serum	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
extracted	NULL
,	NULL
and	NULL
RT-PCR	NULL
was	NULL
performed	NULL
using	NULL
c-jun-specific	NULL
primer	NULL
pairs	NULL
.	NULL

c-jun	NULL
AS	NULL
oligonucleotides	NULL
inhibited	NULL
the	NULL
target	NULL
mRNA	NULL
expression	NULL
in	NULL
both	NULL
PMA-	NULL
and	NULL
serum-stimulated	NULL
U937	NULL
cells	NULL
,	NULL
whereas	NULL
B-actin	NULL
mRNA	NULL
expression	NULL
remained	NULL
unchanged	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
c-jun	NULL
AS	NULL
Oligonucleotides	NULL
on	NULL
PMA-induced	NULL
Functional	NULL
Maturation	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
role	NULL
of	NULL
c-jun	NULL
on	NULL
U937	NULL
cell	NULL
differentiation	NULL
,	NULL
cells	NULL
initially	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
either	NULL
control	NULL
or	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
were	NULL
exposed	NULL
to	NULL
PMA	NULL
,	NULL
and	NULL
the	NULL
two	NULL
markers	NULL
of	NULL
functional	NULL
maturation	NULL
(	NULL
cellular	NULL
adhesion	NULL
and	NULL
NBT	NULL
reduction	NULL
activity	NULL
)	NULL
were	NULL
evaluated	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
cellular	NULL
adhesion	NULL
was	NULL
induced	NULL
rapidly	NULL
by	NULL
PMA	NULL
,	NULL
and	NULL
more	NULL
than	NULL
90	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
became	NULL
adherent	NULL
within	NULL
24	NULL
h	NULL
and	NULL
%	NULL
adhesion	NULL
u	NULL
Time	NULL
(	NULL
hrs	NULL
)	NULL
B	NULL
100	NULL
C	NULL
5	NULL
``	NULL
®	NULL
5	NULL
I	NULL
a	NULL
6°-u	NULL
'	NULL
_	NULL
4	NULL
m	NULL
a	NULL
.	NULL

407	NULL
»	NULL
l	NULL
2°-0L	NULL
;	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
Time	NULL
(	NULL
hrs	NULL
)	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Kinetics	NULL
of	NULL
PMA-induced	NULL
functional	NULL
maturation	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Cells	NULL
treated	NULL
without	NULL
(	NULL
C	NULL
)	NULL
or	NULL
with	NULL
10	NULL
um	NULL
of	NULL
either	NULL
control	NULL
(	NULL
@	NULL
)	NULL
or	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
[	NULL
AS-1	NULL
(	NULL
]	NULL
)	NULL
or	NULL
AS-2	NULL
(	NULL
A	NULL
)	NULL
]	NULL
were	NULL
induced	NULL
to	NULL
differentiate	NULL
by	NULL
exposure	NULL
to	NULL
160	NULL
nm	NULL
PMA	NULL
.	NULL

The	NULL
percentages	NULL
of	NULL
adhesion	NULL
(	NULL
4	NULL
)	NULL
and	NULL
NBT	NULL
reduction	NULL
(	NULL
B	NULL
)	NULL
in	NULL
total	NULL
viable	NULL
cells	NULL
were	NULL
determined	NULL
at	NULL
24	NULL
h	NULL
and	NULL
72	NULL
h	NULL
after	NULL
PMA	NULL
exposure	NULL
.	NULL

Values	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplicate	NULL
wells	NULL
.	NULL
'	NULL

,	NULL
P	NULL
<	NULL
0.01	NULL
,	NULL
compared	NULL
to	NULL
the	NULL
values	NULL
of	NULL
untreated	NULL
and	NULL
C-JUN	NULL
AS-treated	NULL
cells	NULL
by	NULL
unpaired	NULL
Student	NULL
's	NULL
t	NULL
test	NULL
.	NULL

reached	NULL
a	NULL
plateau	NULL
thereafter	NULL
.	NULL

Pretreatment	NULL
of	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
and	NULL
marked	NULL
decrease	NULL
in	NULL
PMA-induced	NULL
cell	NULL
adhesion	NULL
,	NULL
whereas	NULL
the	NULL
induction	NULL
of	NULL
NBT	NULL
reduction	NULL
activity	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

78	NULL
)	NULL
.	NULL

To	NULL
clarify	NULL
whether	NULL
the	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
selectively	NULL
suppress	NULL
PMA-induced	NULL
cell	NULL
adhesion	NULL
,	NULL
we	NULL
counted	NULL
the	NULL
absolute	NULL
cell	NULL
number	NULL
of	NULL
NBT-positive	NULL
or	NULL
-negative	NULL
cells	NULL
in	NULL
adherent	NULL
and	NULL
floating	NULL
cell	NULL
fractions	NULL
separately	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
neither	NULL
the	NULL
number	NULL
of	NULL
total	NULL
viable	NULL
cells	NULL
nor	NULL
the	NULL
number	NULL
of	NULL
NBT-positive	NULL
cells	NULL
(	NULL
hatched	NULL
boxes	NULL
)	NULL
was	NULL
different	NULL
between	NULL
untreated-	NULL
and	NULL
AS-treated	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
the	NULL
number	NULL
of	NULL
adherent	NULL
cells	NULL
(	NULL
gray	NULL
boxes	NULL
)	NULL
was	NULL
significantly	NULL
reduced	NULL
by	NULL
AS	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
20	NULL
é	NULL
15-	NULL
«	NULL
i	NULL
:	NULL
e	NULL
V	NULL
a	NULL
a	NULL
#	NULL
s	NULL
0	NULL
AS	NULL
1	NULL
_	NULL
AS	NULL
2	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Effect	NULL
of	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
on	NULL
PMA-induced	NULL
functional	NULL
maturation	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Cells	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
10	NULL
um	NULL
of	NULL
either	NULL
control	NULL
or	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
(	NULL
AS-1	NULL
or	NULL
AS-2	NULL
)	NULL
were	NULL
induced	NULL
to	NULL
differentiate	NULL
by	NULL
the	NULL
exposure	NULL
to	NULL
160	NULL
nm	NULL
PMA	NULL
.	NULL

Absolute	NULL
cell	NULL
number	NULL
of	NULL
both	NULL
adherent	NULL
(	NULL
gray	NULL
boxes	NULL
)	NULL
and	NULL
floating	NULL
(	NULL
white	NULL
boxes	NULL
)	NULL
cells	NULL
,	NULL
and	NULL
NBT	NULL
positive	NULL
(	NULL
hatched	NULL
boxes	NULL
)	NULL
and	NULL
negative	NULL
(	NULL
solid	NULL
boxes	NULL
)	NULL
cells	NULL
were	NULL
counted	NULL
separately	NULL
using	NULL
a	NULL
hemocytometer	NULL
at	NULL
24	NULL
h	NULL
after	NULL
PMA	NULL
exposure	NULL
.	NULL

Values	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
determinations	NULL
.	NULL

untreated	NULL
control	NULL
treatment	NULL
.	NULL

Furthermore	NULL
,	NULL
although	NULL
most	NULL
NBT-positive	NULL
cells	NULL
were	NULL
found	NULL
in	NULL
adherent	NULL
cell	NULL
fractions	NULL
in	NULL
untreated	NULL
or	NULL
control	NULL
oligonucleotide-treated	NULL
cells	NULL
(	NULL
hatched	NULL
boxes	NULL
were	NULL
found	NULL
only	NULL
in	NULL
gray	NULL
box	NULL
in	NULL
untreated	NULL
and	NULL
control	NULL
columns	NULL
)	NULL
,	NULL
a	NULL
number	NULL
of	NULL
NBT-positive	NULL
cells	NULL
were	NULL
found	NULL
even	NULL
in	NULL
the	NULL
floating	NULL
cell	NULL
fractions	NULL
if	NULL
the	NULL
cells	NULL
had	NULL
been	NULL
treated	NULL
with	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
(	NULL
hatched	NULL
boxes	NULL
were	NULL
found	NULL
in	NULL
both	NULL
gray	NULL
and	NULL
white	NULL
boxes	NULL
in	NULL
AS-1	NULL
and	NULL
AS-2	NULL
columns	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
c-jun	NULL
AS	NULL
oligonucleotides	NULL
suppress	NULL
only	NULL
cell	NULL
adhesion	NULL
,	NULL
without	NULL
exhibiting	NULL
any	NULL
effect	NULL
on	NULL
NBT	NULL
reduction	NULL
activity	NULL
.	NULL

Discussion	NULL
The	NULL
c-jun	NULL
proto-oncogene	NULL
is	NULL
characterized	NULL
as	NULL
an	NULL
IEG	NULL
and	NULL
is	NULL
thought	NULL
to	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
U937	NULL
cell	NULL
differentiation	NULL
.	NULL

However	NULL
,	NULL
most	NULL
of	NULL
the	NULL
previous	NULL
reports	NULL
describing	NULL
the	NULL
functional	NULL
link	NULL
between	NULL
c-jun	NULL
expression	NULL
and	NULL
U937	NULL
cell	NULL
differentiation	NULL
are	NULL
based	NULL
on	NULL
the	NULL
change	NULL
in	NULL
c-jun	NULL
expression	NULL
level	NULL
during	NULL
the	NULL
induction	NULL
of	NULL
differentiation	NULL
,	NULL
and	NULL
few	NULL
reports	NULL
show	NULL
evidence	NULL
for	NULL
a	NULL
correlation	NULL
between	NULL
c-jun	NULL
and	NULL
cell	NULL
differentiation	NULL
.	NULL

Because	NULL
PMA	NULL
is	NULL
known	NULL
to	NULL
stimulate	NULL
c-jun	NULL
expression	NULL
(	NULL
13	NULL
)	NULL
,	NULL
the	NULL
answer	NULL
to	NULL
the	NULL
fundamental	NULL
question	NULL
of	NULL
whether	NULL
c-jun	NULL
expression	NULL
is	NULL
a	NULL
mainspring	NULL
or	NULL
a	NULL
byproduct	NULL
during	NULL
PMA-induced	NULL
differentiation	NULL
of	NULL
U937	NULL
cells	NULL
remains	NULL
unclear	NULL
.	NULL

The	NULL
present	NULL
study	NULL
using	NULL
AS	NULL
oligonucleotides	NULL
provided	NULL
significant	NULL
insight	NULL
into	NULL
this	NULL
inquiry	NULL
.	NULL

The	NULL
results	NULL
demonstrated	NULL
that	NULL
the	NULL
suppression	NULL
of	NULL
c-jun	NULL
expression	NULL
inhibited	NULL
PMA-induced	NULL
cell	NULL
adhesion	NULL
but	NULL
not	NULL
PMA-induced	NULL
NBT	NULL
reduction	NULL
activity	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
immediate	NULL
early	NULL
response	NULL
of	NULL
c-jun	NULL
expression	NULL
relates	NULL
to	NULL
cellular	NULL
adherence	NULL
but	NULL
does	NULL
not	NULL
relate	NULL
to	NULL
NBT	NULL
reduction	NULL
activity	NULL
during	NULL
PMA-induced	NULL
differentiation	NULL
of	NULL
U937	NULL
cells	NULL
.	NULL

Two	NULL
lines	NULL
of	NULL
evidence	NULL
support	NULL
this	NULL
conclusion	NULL
:	NULL
(	NULL
a	NULL
)	NULL
PMA-induced	NULL
cell	NULL
adhesion	NULL
was	NULL
significantly	NULL
suppressed	NULL
at	NULL
both	NULL
24	NULL
h	NULL
and	NULL
72	NULL
h	NULL
after	NULL
stimu-	NULL
lation	NULL
,	NULL
whereas	NULL
NBT	NULL
reduction	NULL
activity	NULL
was	NULL
never	NULL
affected	NULL
by	NULL
c-jun	NULL
AS	NULL
treatment	NULL
,	NULL
although	NULL
these	NULL
two	NULL
markers	NULL
of	NULL
differentiation	NULL
were	NULL
measured	NULL
in	NULL
identical	NULL
cells	NULL
of	NULL
culture	NULL
;	NULL
and	NULL
(	NULL
b	NULL
)	NULL
under	NULL
normal	NULL
conditions	NULL
,	NULL
NBT	NULL
reduction	NULL
activity	NULL
was	NULL
usually	NULL
found	NULL
in	NULL
the	NULL
cells	NULL
that	NULL
showed	NULL
adherent	NULL
activity	NULL
.	NULL

After	NULL
c-jun	NULL
AS	NULL
treatment	NULL
,	NULL
however	NULL
,	NULL
NBT	NULL
reduction	NULL
activity	NULL
was	NULL
seen	NULL
even	NULL
in	NULL
cells	NULL
that	NULL
could	NULL
not	NULL
show	NULL
adherent	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
the	NULL
acquisition	NULL
of	NULL
cellular	NULL
adherence	NULL
was	NULL
selectively	NULL
inhibited	NULL
,	NULL
whereas	NULL
NBT	NULL
reduction	NULL
activity	NULL
remained	NULL
unchanged	NULL
.	NULL

Although	NULL
recent	NULL
AS	NULL
technologies	NULL
provide	NULL
an	NULL
opportunity	NULL
to	NULL
inhibit	NULL
target	NULL
gene	NULL
expression	NULL
(	NULL
34	NULL
)	NULL
,	NULL
one	NULL
of	NULL
the	NULL
most	NULL
critical	NULL
steps	NULL
in	NULL
oligonucleotide-based	NULL
AS	NULL
research	NULL
is	NULL
to	NULL
distinguish	NULL
sequence-specific	NULL
activities	NULL
from	NULL
sequence-nonspecific	NULL
ef-fects	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
in	NULL
designing	NULL
specific	NULL
oligonucleotide	NULL
sequences	NULL
,	NULL
we	NULL
have	NULL
conducted	NULL
extensive	NULL
analysis	NULL
for	NULL
:	NULL
(	NULL
a	NULL
)	NULL
the	NULL
sequence	NULL
similarity	NULL
of	NULL
oligonucleotides	NULL
;	NULL
(	NULL
b	NULL
)	NULL
optimal	NULL
Tm	NULL
in	NULL
intracellular	NULL
physiological	NULL
condition	NULL
;	NULL
(	NULL
c	NULL
)	NULL
optimal	NULL
length	NULL
of	NULL
oligonucleotides	NULL
;	NULL
(	NULL
d	NULL
)	NULL
hybridization	NULL
sites	NULL
on	NULL
the	NULL
target	NULL
mRNA	NULL
;	NULL
and	NULL
(	NULL
e	NULL
)	NULL
the	NULL
possibility	NULL
of	NULL
forming	NULL
a	NULL
secondary	NULL
structure	NULL
of	NULL
both	NULL
oligonucieotides	NULL
and	NULL
target	NULL
genes	NULL
,	NULL
by	NULL
using	NULL
our	NULL
newly	NULL
developed	NULL
computer	NULL
program	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Through	NULL
the	NULL
analysis	NULL
,	NULL
we	NULL
selected	NULL
20	NULL
different	NULL
oligonucleotides	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
Tms	NULL
and	NULL
lengths	NULL
and	NULL
identified	NULL
at	NULL
least	NULL
two	NULL
active	NULL
oligonucleotides	NULL
in	NULL
different	NULL
areas	NULL
of	NULL
the	NULL
target	NULL
c-jun	NULL
(	NULL
AS-1	NULL
,	NULL
AUG	NULL
starting	NULL
codon	NULL
;	NULL
AS-2	NULL
,	NULL
other	NULL
coding	NULL
sequence	NULL
region	NULL
)	NULL
.	NULL

RT-PCR	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
demonstrated	NULL
that	NULL
the	NULL
oligonucleotides	NULL
revealed	NULL
significant	NULL
reduction	NULL
of	NULL
c-jun	NULL
expression	NULL
at	NULL
both	NULL
the	NULL
mRNA	NULL
and	NULL
protein	NULL
levels	NULL
but	NULL
showed	NULL
unchanged	NULL
levels	NULL
of	NULL
B-actin	NULL
control	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
each	NULL
sequence	NULL
was	NULL
carefully	NULL
analyzed	NULL
for	NULL
its	NULL
sequence	NULL
similarity/	NULL
dissimilarity	NULL
and	NULL
hybridizability	NULL
against	NULL
other	NULL
published	NULL
gene	NULL
sequences	NULL
to	NULL
show	NULL
sequence	NULL
specificity	NULL
.	NULL

Hybridizability	NULL
is	NULL
based	NULL
on	NULL
the	NULL
nearest	NULL
neighbor	NULL
calculation	NULL
of	NULL
the	NULL
free	NULL
hybridization	NULL
energy	NULL
between	NULL
the	NULL
AS	NULL
sequences	NULL
and	NULL
all	NULL
other	NULL
published	NULL
gene	NULL
sequences	NULL
in	NULL
the	NULL
GenBank	NULL
primate	NULL
database	NULL
.	NULL

Based	NULL
on	NULL
these	NULL
analyses	NULL
,	NULL
both	NULL
oligonucleotides	NULL
AS-1	NULL
and	NULL
AS-2	NULL
were	NULL
highly	NULL
specific	NULL
to	NULL
c-jun	NULL
but	NULL
not	NULL
to	NULL
all	NULL
other	NULL
published	NULL
sequences	NULL
,	NULL
including	NULL
the	NULL
members	NULL
of	NULL
the	NULL
IEG	NULL
family	NULL
,	NULL
such	NULL
as	NULL
jun	NULL
B	NULL
,	NULL
jun	NULL
D	NULL
,	NULL
c-fos	NULL
,	NULL
fra-1	NULL
,	NULL
fra-2	NULL
,	NULL
and	NULL
c-myc	NULL
(	NULL
as	NULL
summarized	NULL
in	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
AS-1	NULL
and	NULL
AS-2	NULL
are	NULL
more	NULL
likely	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
c-jun	NULL
activities	NULL
but	NULL
not	NULL
in	NULL
simple	NULL
sequence-nonspecific	NULL
activity	NULL
.	NULL

The	NULL
protein	NULL
products	NULL
of	NULL
c-jun	NULL
gene	NULL
dimerize	NULL
with	NULL
c-Fos	NULL
protein	NULL
,	NULL
forming	NULL
the	NULL
nuclear	NULL
complex	NULL
AP-1	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Jun/Fos	NULL
family	NULL
(	NULL
.e	NULL
.	NULL

,	NULL
junB	NULL
,	NULL
junD	NULL
,	NULL
fosB	NULL
,	NULL
fra-1	NULL
,	NULL
and	NULL
fra-2	NULL
)	NULL
and	NULL
the	NULL
members	NULL
of	NULL
ATF/cyclic	NULL
AMP	NULL
response	NULL
element	NULL
binding	NULL
protein	NULL
family	NULL
such	NULL
as	NULL
ATF2	NULL
can	NULL
form	NULL
homo-	NULL
or	NULL
heterodimers	NULL
that	NULL
show	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
35-38	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
after	NULL
AS	NULL
inhibition	NULL
of	NULL
c-jun	NULL
expression	NULL
,	NULL
these	NULL
genes	NULL
might	NULL
compensate	NULL
for	NULL
c-jun	NULL
gene	NULL
function	NULL
by	NULL
showing	NULL
transcription	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
it	NULL
seems	NULL
less	NULL
likely	NULL
that	NULL
this	NULL
would	NULL
occur	NULL
in	NULL
only	NULL
the	NULL
process	NULL
of	NULL
NBT	NULL
reduction	NULL
activity	NULL
but	NULL
not	NULL
in	NULL
the	NULL
process	NULL
of	NULL
cellular	NULL
adher-ence	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
that	NULL
c-Jun/Fos	NULL
heterodimers	NULL
reveal	NULL
enhanced	NULL
DNA	NULL
binding	NULL
activity	NULL
compared	NULL
to	NULL
other	NULL
dimers	NULL
(	NULL
39	NULL
)	NULL
,	NULL
implicating	NULL
that	NULL
c-Jun/Fos	NULL
heterodimers	NULL
could	NULL
not	NULL
neutralize	NULL
c-jun	NULL
suppression	NULL
com-pletely	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
differences	NULL
in	NULL
biological	NULL
response	NULL
1009	NULL
1010	NULL
_	NULL
Role	NULL
of	NULL
c-jun	NULL
in	NULL
Hematopoietic	NULL
Cell	NULL
Differentiation	NULL
Table	NULL
2	NULL
-	NULL
Specificity	NULL
of	NULL
oligonucleotide	NULL
sequences	NULL
Genes	NULL
Locus	NULL
Position	NULL
AG	NULL
``	NULL
Sequence	NULL
(	NULL
sense	NULL
)	NULL
``	NULL
AS-1	NULL
15.36	NULL
-	NULL
ACTGTTCTATGACTG	NULL
c-jun	NULL
HUMJUNA	NULL
1253	NULL
15.36	NULL
-	NULL
--	NULL
--	NULL
--	NULL
-_-_	NULL
--	NULL
©	NULL
jun	NULL
B	NULL
HSJUNB	NULL
1744	NULL
4.63	NULL
-	NULL
TT	NULL
--	NULL
--	NULL
T-TTA-T	NULL
jun	NULL
D	NULL
HSJUND	NULL
1516	NULL
4.63	NULL
-	NULL
TT	NULL
--	NULL
--	NULL
G-TTGT	NULL
c-fos	NULL
HSCFOS	NULL
1173	NULL
8.55	NULL
-	NULL
TT	NULL
--	NULL
--	NULL
G	NULL
--	NULL
--	NULL
T	NULL
fra-1	NULL
HSFRA1M	NULL
432	NULL
3.61	NULL
TGCAGG-GGA	NULL
--	NULL
-fra-2	NULL
HSFRAZM	NULL
655	NULL
2.80	NULL
-	NULL
G-	NULL
--	NULL
AG-GGTGAAA	NULL
c-mye	NULL
_	NULL
HSMYC1	NULL
585	NULL
4.94	NULL
_	NULL
CAG-AA	NULL
--	NULL
--	NULL
-	NULL
-CT	NULL
AS-2	NULL
16.37	NULL
-	NULL
ATGAACCACGTTAAC	NULL
c-jun	NULL
-_	NULL
HUMJUNA	NULL
__	NULL
2197	NULL
_	NULL
16.37	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-jun	NULL
B	NULL
__	NULL
HSJUNB	NULL
698	NULL
-	NULL
12.30	NULL
--	NULL
--	NULL
--	NULL
-	NULL
G-CA	NULL
jun	NULL
D	NULL
_	NULL
HSJUND	NULL
855	NULL
7.46	NULL
-	NULL
C-C-G	NULL
--	NULL
--	NULL
C	NULL
--	NULL
-c-fos	NULL
-	NULL
HSCFOS	NULL
279	NULL
5.50	NULL
-	NULL
-ACCG	NULL
--	NULL
-A-G-T	NULL
fra-1	NULL
HSFRA1TM	NULL
bes	NULL
5.24	NULL
-	NULL
T	NULL
--	NULL
--	NULL
TGAGGC	NULL
--	NULL
fra-2	NULL
HSFRAZM	NULL
83s	NULL
6.08	NULL
-	NULL
TC	NULL
--	NULL
-T	NULL
--	NULL
CTT-	NULL
c-mye	NULL
_	NULL
HSMYC1	NULL
1453	NULL
_	NULL
693	NULL
-G-TG	NULL
--	NULL
--	NULL
CTC-Control	NULL
17.33	NULL
-	NULL
CTCATGCCACTICAG	NULL
c-jun	NULL
__	NULL
HUMJUNA	NULL
_	NULL
876	NULL
_	NULL
8.56	NULL
GG-CG	NULL
--	NULL
--	NULL
G	NULL
--	NULL
jun	NULL
B	NULL
__	NULL
HSJUNB	NULL
1237	NULL
_	NULL
6.36	NULL
-ATGAC	NULL
--	NULL
-G	NULL
--	NULL
-jun	NULL
D	NULL
_	NULL
HSJUND	NULL
854	NULL
_	NULL
7.48	NULL
-CTCA	NULL
--	NULL
-G	NULL
--	NULL
A	NULL
c-fos	NULL
_	NULL
HSCFOS	NULL
2964	NULL
_	NULL
8.77	NULL
-CAG	NULL
--	NULL
A	NULL
--	NULL
--	NULL
-frail	NULL
__	NULL
HSFRATIM	NULL
|_	NULL
873	NULL
_	NULL
715	NULL
-AG	NULL
--	NULL
--	NULL
CCT	NULL
--	NULL
_	NULL
HSFRAZM	NULL
__	NULL
317	NULL
4.37	NULL
-CAT	NULL
--	NULL
G	NULL
--	NULL
CA-C-c-myc	NULL
_	NULL
HSMYC1	NULL
1452	NULL
_	NULL
748	NULL
GaG	NULL
@	NULL
--	NULL
-G-TC	NULL
*	NULL
Calculated	NULL
maximum	NULL
AG	NULL
with	NULL
nearest	NULL
neighbor	NULL
model	NULL
.	NULL

®	NULL
Sequences	NULL
are	NULL
sense	NULL
orientation	NULL
for	NULL
analysis	NULL
against	NULL
GenBank	NULL
database	NULL
.	NULL

©	NULL
-	NULL
indicates	NULL
identical	NULL
nucleotide	NULL
to	NULL
that	NULL
of	NULL
antisense	NULL
oligonucleotides	NULL
.	NULL

between	NULL
the	NULL
members	NULL
of	NULL
the	NULL
jun	NULL
gene	NULL
family	NULL
has	NULL
been	NULL
reported	NULL
previously	NULL
.	NULL

For	NULL
example	NULL
,	NULL
junB	NULL
and	NULL
junD	NULL
differ	NULL
from	NULL
c-jun	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
induce	NULL
oncogenic	NULL
transformation	NULL
of	NULL
fibroblasts	NULL
(	NULL
40-43	NULL
)	NULL
and	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
inhibit	NULL
steroid	NULL
hormone	NULL
receptor	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
or	NULL
muscle	NULL
differentiation	NULL
factor	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
was	NULL
reported	NULL
that	NULL
constitutive	NULL
c-Jun	NULL
expression	NULL
induced	NULL
the	NULL
acquisition	NULL
of	NULL
phagocytic	NULL
activity	NULL
but	NULL
did	NULL
not	NULL
develop	NULL
cellular	NULL
adherence	NULL
using	NULL
c-jun-transfected	NULL
U937	NULL
cells	NULL
(	NULL
47	NULL
)	NULL
.	NULL

These	NULL
results	NULL
imply	NULL
that	NULL
c-Jun	NULL
expression	NULL
relates	NULL
to	NULL
phagocytic	NULL
activity	NULL
but	NULL
not	NULL
to	NULL
cellular	NULL
adherence	NULL
during	NULL
PMA-induced	NULL
differentiation	NULL
of	NULL
U937	NULL
cells	NULL
.	NULL

Although	NULL
these	NULL
findings	NULL
are	NULL
in	NULL
contrast	NULL
to	NULL
those	NULL
presented	NULL
here	NULL
,	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
c-Jun	NULL
protein	NULL
may	NULL
induce	NULL
additional	NULL
gene	NULL
expression	NULL
followed	NULL
by	NULL
some	NULL
phenotypic	NULL
modulation	NULL
,	NULL
and	NULL
therefore	NULL
it	NULL
is	NULL
not	NULL
associated	NULL
with	NULL
physiological	NULL
condition	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Because	NULL
c-Jun	NULL
protein	NULL
is	NULL
transiently	NULL
expressed	NULL
as	NULL
an	NULL
immediate	NULL
early	NULL
event	NULL
only	NULL
after	NULL
appropriate	NULL
stimulation	NULL
in	NULL
U937	NULL
cells	NULL
,	NULL
we	NULL
think	NULL
the	NULL
AS	NULL
approach	NULL
,	NULL
which	NULL
can	NULL
selectively	NULL
inhibit	NULL
target	NULL
gene	NULL
expression	NULL
,	NULL
is	NULL
an	NULL
appropriate	NULL
way	NULL
to	NULL
examine	NULL
the	NULL
distinct	NULL
role	NULL
of	NULL
such	NULL
an	NULL
IEG	NULL
as	NULL
c-jun	NULL
.	NULL

Recent	NULL
studies	NULL
concerning	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
control	NULL
have	NULL
focused	NULL
on	NULL
delineating	NULL
signal	NULL
transduction	NULL
pathways	NULL
,	NULL
especially	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
.	NULL

Many	NULL
receptor	NULL
tyrosine	NULL
kinases	NULL
or	NULL
cytokine	NULL
receptors	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
MAP	NULL
kinase	NULL
cascades	NULL
,	NULL
which	NULL
involve	NULL
the	NULL
small	NULL
GTP-binding	NULL
protein	NULL
p21	NULL
``	NULL
*	NULL
(	NULL
48	NULL
,	NULL
49	NULL
)	NULL
.	NULL

The	NULL
activated	NULL
Ras	NULL
protein	NULL
contributes	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
MAPK	NULL
kinase	NULL
(	NULL
MAPKK	NULL
,	NULL
also	NULL
known	NULL
as	NULL
MEK	NULL
)	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
activates	NULL
MAP	NULL
kinases	NULL
,	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
,	NULL
and	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
.	NULL

Once	NULL
activated	NULL
,	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
and	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
they	NULL
phosphorylate	NULL
transcription	NULL
factors	NULL
(	NULL
f.e	NULL
.	NULL

,	NULL
Elk-1	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
ATF2	NULL
)	NULL
leading	NULL
to	NULL
IEG	NULL
induction	NULL
(	NULL
50-52	NULL
)	NULL
.	NULL

Because	NULL
MAP	NULL
kinase	NULL
activation	NULL
is	NULL
associeted	NULL
with	NULL
both	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
(	NULL
53	NULL
)	NULL
,	NULL
the	NULL
mechanisms	NULL
that	NULL
determine	NULL
whether	NULL
a	NULL
stimulus	NULL
elicits	NULL
proliferation	NULL
or	NULL
differentiation	NULL
have	NULL
yet	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

Further	NULL
experiments	NULL
modulating	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
proliferation/differentiation-related	NULL
genes	NULL
as	NULL
well	NULL
as	NULL
examining	NULL
the	NULL
composition	NULL
of	NULL
AP-1	NULL
complex	NULL
in	NULL
PMA-stimulated	NULL
cells	NULL
will	NULL
help	NULL
elucidate	NULL
the	NULL
complex	NULL
signal	NULL
transduction	NULL
cascade	NULL
in	NULL
hematopoietic	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Oligodeoxynucleotides	NULL
.	NULL

A	NULL
series	NULL
of	NULL
c-jun-specific	NULL
AS	NULL
oligonucleotides	NULL
were	NULL
designed	NULL
by	NULL
a	NULL
computer	NULL
program	NULL
,	NULL
HYBsimulator	NULL
``	NULL
``	NULL
``	NULL
(	NULL
Advanced	NULL
Gene	NULL
Computing	NULL
Technologies	NULL
,	NULL
Irvine	NULL
,	NULL
CA	NULL
;	NULL
Refs	NULL
.	NULL

32	NULL
and	NULL
33	NULL
)	NULL
.	NULL

Phosphorothicate-modified	NULL
oligonucleotides	NULL
were	NULL
synthesized	NULL
by	NULL
an	NULL
automated	NULL
model	NULL
380B	NULL
DNA	NULL
synthesizer	NULL
(	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
using	NULL
standard	NULL
phosphoramidite	NULL
chemistry	NULL
.	NULL

For	NULL
the	NULL
preparation	NULL
of	NULL
phosphorothioate	NULL
link-ages	NULL
,	NULL
the	NULL
standard	NULL
oxidation	NULL
bottle	NULL
was	NULL
replaced	NULL
by	NULL
tetraethylthiuram	NULL
disulfide	NULL
(	NULL
Applied	NULL
Biosystems	NULL
)	NULL
in	NULL
acetonitrite	NULL
.	NULL

After	NULL
cleavage	NULL
from	NULL
the	NULL
column	NULL
and	NULL
deprotecting	NULL
in	NULL
ammonium	NULL
hydroxide	NULL
at	NULL
55°C	NULL
for	NULL
10	NULL
h	NULL
,	NULL
the	NULL
oligomers	NULL
were	NULL
dissolved	NULL
in	NULL
water	NULL
and	NULL
were	NULL
purified	NULL
by	NULL
two	NULL
rounds	NULL
of	NULL
ethanol	NULL
precipitation	NULL
.	NULL

The	NULL
length	NULL
and	NULL
purity	NULL
of	NULL
each	NULL
oligonucleotide	NULL
was	NULL
analyzed	NULL
by	NULL
a	NULL
15	NULL
%	NULL
PAGE	NULL
,	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
full-length	NULL
material	NULL
was	NULL
more	NULL
than	NULL
95	NULL
%	NULL
.	NULL

All	NULL
oligonucleotides	NULL
were	NULL
freshly	NULL
dissolved	NULL
in	NULL
Dulbecco	NULL
's	NULL
PBS	NULL
(	NULL
Hyclone	NULL
Laboratories	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
for	NULL
working	NULL
solution	NULL
.	NULL

Cells	NULL
and	NULL
Culture	NULL
Condition	NULL
.	NULL

Human	NULL
monobiastic	NULL
cell	NULL
line	NULL
U937	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
and	NULL
was	NULL
maintained	NULL
in	NULL
suspension	NULL
culture	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
Hyclone	NULL
Laboratories	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
(	NULL
Hyclone	NULL
Laboratories	NULL
)	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
/95	NULL
%	NULL
air	NULL
.	NULL

Passage	NULL
was	NULL
performed	NULL
every	NULL
3-4	NULL
days	NULL
and	NULL
was	NULL
seeded	NULL
at	NULL
an	NULL
initial	NULL
concentration	NULL
of	NULL
2	NULL
x	NULL
10°	NULL
cells/ml	NULL
.	NULL

For	NULL
the	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
oligonucleotides	NULL
,	NULL
after	NULL
two	NULL
rounds	NULL
of	NULL
passage	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
,	NULL
were	NULL
resuspended	NULL
in	NULL
100	NULL
l	NULL
of	NULL
RPMI	NULL
1640	NULL
containing	NULL
0.5	NULL
%	NULL
FBS	NULL
,	NULL
and	NULL
were	NULL
seeded	NULL
in	NULL
96-well	NULL
plates	NULL
(	NULL
Costar	NULL
Corp.	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
at	NULL
the	NULL
density	NULL
of	NULL
2500	NULL
cells/well	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
oligonucleotides	NULL
for	NULL
24	NULL
h	NULL
,	NULL
and	NULL
serum	NULL
was	NULL
added	NULL
to	NULL
reach	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
%	NULL
.	NULL

Then	NULL
,	NULL
culture	NULL
was	NULL
continued	NULL
for	NULL
an	NULL
additional	NULL
1-3	NULL
days	NULL
.	NULL

For	NULL
the	NULL
induction	NULL
of	NULL
cellular	NULL
differentiation	NULL
,	NULL
cells	NULL
were	NULL
seeded	NULL
in	NULL
24-well	NULL
plates	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
10	NULL
%	NULL
FBS/RPMI	NULL
1640	NULL
at	NULL
the	NULL
cell	NULL
density	NULL
of	NULL
2	NULL
x	NULL
10°	NULL
cells/ml	NULL
and	NULL
were	NULL
incubated	NULL
with	NULL
160	NULL
nm	NULL
PMA	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

PH	NULL
]	NULL
JThymidine	NULL
Uptake	NULL
of	NULL
Cells	NULL
.	NULL

Celis	NULL
were	NULL
pulsed	NULL
with	NULL
0.5	NULL
mCi	NULL
PHJthymidine/well	NULL
for	NULL
the	NULL
final	NULL
6	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
then	NULL
they	NULL
were	NULL
harvested	NULL
onto	NULL
glass	NULL
fiber	NULL
filters	NULL
(	NULL
Cambridge	NULL
Technology	NULL
,	NULL
Watertown	NULL
,	NULL
MA	NULL
)	NULL
using	NULL
a	NULL
semiautomated	NULL
PHD	NULL
model	NULL
290	NULL
cell	NULL
harvester	NULL
(	NULL
Cambridge	NULL
Technology	NULL
}	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
incorporated	NULL
tritium	NULL
was	NULL
measured	NULL
by	NULL
a	NULL
liquid	NULL
scintillation	NULL
counter	NULL
(	NULL
LS6000	NULL
ic	NULL
;	NULL
Beckman	NULL
Instruments	NULL
,	NULL
Fullerton	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis	NULL
.	NULL

Cells	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
,	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
ice-cold	NULL
PBS	NULL
,	NULL
and	NULL
were	NULL
lysed	NULL
on	NULL
ice	NULL
in	NULL
100	NULL
Ll	NULL
of	NULL
standard	NULL
radioimmunoprecipitation	NULL
assay	NULL
buffer	NULL
[	NULL
0.15	NULL
m	NULL
NaCl	NULL
,	NULL
50	NULL
mm	NULL
Tris-HCI	NULL
(	NULL
pH8.0	NULL
)	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
1	NULL
%	NULL
NP4O0	NULL
]	NULL
containing	NULL
100	NULL
ug/ml	NULL
phe-nylmethyisulfonyifluoride	NULL
and	NULL
1	NULL
ug/ml	NULL
!	NULL

each	NULL
of	NULL
aprotinin	NULL
,	NULL
pepstatin	NULL
,	NULL
and	NULL
leupeptin	NULL
.	NULL

Lysates	NULL
were	NULL
then	NULL
sonicated	NULL
briefly	NULL
to	NULL
reduce	NULL
viscosity	NULL
and	NULL
were	NULL
clarified	NULL
by	NULL
centrifugation	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Twenty	NULL
ug	NULL
of	NULL
total	NULL
protein	NULL
were	NULL
electrophoresed	NULL
on	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
and	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
blocked	NULL
in	NULL
3	NULL
%	NULL
gelatin/TBS	NULL
[	NULL
20	NULL
mm	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.6	NULL
)	NULL
and	NULL
0.9	NULL
%	NULL
NaCI	NULL
]	NULL
for	NULL
10	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
then	NULL
were	NULL
incubated	NULL
with	NULL
rabbit	NULL
anti-human	NULL
c-Jun	NULL
antibody	NULL
(	NULL
Oncogene	NULL
Science	NULL
,	NULL
Uniondale	NULL
,	NULL
NY	NULL
)	NULL
diluted	NULL
1:10	NULL
in	NULL
1	NULL
%	NULL
gelatin/TBS	NULL
for	NULL
2	NULL
h	NULL
,	NULL
followed	NULL
by	NULL
goat	NULL
anti-rabbit	NULL
1gG-alkaline-phosphatase	NULL
conjugate	NULL
(	NULL
Sigma	NULL
)	NULL
diluted	NULL
1:10	NULL
in	NULL
1	NULL
%	NULL
gelatin/	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
TBS	NULL
for	NULL
1	NULL
h.	NULL
Color	NULL
development	NULL
was	NULL
performed	NULL
by	NULL
alkaline-phosphatase	NULL
conjugate	NULL
substrate	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
)	NULL
,	NULL
according	NULL
to	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

RT-PCR	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
1	NULL
x	NULL
10°	NULL
cells	NULL
by	NULL
a	NULL
procedure	NULL
using	NULL
the	NULL
acid	NULL
guanidinium	NULL
thiocyanate-pheno	NULL
!	NULL

chloroform	NULL
method	NULL
.	NULL

Total	NULL
mRNA	NULL
was	NULL
captured	NULL
by	NULL
biotinylated	NULL
oligo-deoxythymidine	NULL
and	NULL
was	NULL
purified	NULL
by	NULL
streptavidine	NULL
paramagnetic	NULL
particles	NULL
(	NULL
Promega	NULL
,	NULL
Mad-ison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Randomly	NULL
primed	NULL
cDNA	NULL
was	NULL
prepared	NULL
from	NULL
isolated	NULL
mRNA	NULL
by	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
after	NULL
PCR	NULL
amplification	NULL
by	NULL
thermal	NULL
cycler	NULL
(	NULL
Perkin	NULL
Elmer	NULL
Cetus	NULL
,	NULL
Norwalk	NULL
,	NULL
CT	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
primer	NULL
pairs	NULL
used	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
c-jun	NULL
sense	NULL
primer	NULL
,	NULL
5'-GTGACCGCGACTTTTCAAAGC-3	NULL
'	NULL
;	NULL
AS	NULL
primer	NULL
,	NULL
5'-CGTTGCGGGACTGGATTATCAG-3	NULL
'	NULL
;	NULL
B-actin	NULL
sense	NULL
primer	NULL
,	NULL
5'-CTTCGCGGG	NULL
CGACGATGC-3	NULL
'	NULL
;	NULL
and	NULL
AS	NULL
primer	NULL
,	NULL
5'-CGTACATGGCT-GGGGTGTTG-3	NULL
'	NULL
.	NULL

PCR	NULL
amplification	NULL
was	NULL
carmied	NULL
out	NULL
with	NULL
35	NULL
cycles	NULL
for	NULL
c-jun	NULL
and	NULL
25	NULL
cycles	NULL
for	NULL
B-actin	NULL
under	NULL
the	NULL
following	NULL
conditions	NULL
:	NULL
denatured	NULL
at	NULL
94°C	NULL
for	NULL
1	NULL
min	NULL
;	NULL
annealed	NULL
at	NULL
55°C	NULL
for	NULL
1.5	NULL
min	NULL
;	NULL
and	NULL
extended	NULL
at	NULL
72°C	NULL
for	NULL
4	NULL
min	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
electrophoresed	NULL
on	NULL
1.2	NULL
%	NULL
agarose	NULL
gel	NULL
followed	NULL
by	NULL
staining	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
amplified	NULL
DNA	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
appropriate	NULL
cDNA	NULL
,	NULL
the	NULL
PCR	NULL
products	NULL
were	NULL
sub-cloned	NULL
,	NULL
and	NULL
the	NULL
nucleotide	NULL
sequences	NULL
were	NULL
determined	NULL
by	NULL
direct	NULL
se-quencing	NULL
.	NULL

Cell	NULL
Adhesion	NULL
Assay	NULL
.	NULL

Floating	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
simple	NULL
aspira-tion	NULL
,	NULL
then	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
100	NULL
Ll	NULL
of	NULL
RPMI	NULL
1640	NULL
.	NULL

The	NULL
number	NULL
of	NULL
viable	NULL
floating	NULL
cells	NULL
was	NULL
counted	NULL
by	NULL
trypan	NULL
blue	NULL
dye	NULL
exclusion	NULL
,	NULL
using	NULL
a	NULL
hemocytometer	NULL
.	NULL

Adherent	NULL
cells	NULL
were	NULL
disaggregated	NULL
by	NULL
a	NULL
15-min	NULL
incubation	NULL
with	NULL
50	NULL
l	NULL
trypsin-EDTA	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
were	NULL
harvested	NULL
thoroughly	NULL
.	NULL

Large	NULL
clumps	NULL
of	NULL
adherent	NULL
cells	NULL
were	NULL
dispersed	NULL
by	NULL
vortex	NULL
and/or	NULL
repeated	NULL
passage	NULL
through	NULL
pipette	NULL
before	NULL
counting	NULL
on	NULL
a	NULL
hemocytometer	NULL
.	NULL

Cells	NULL
in	NULL
small	NULL
clumps	NULL
were	NULL
counted	NULL
as	NULL
separate	NULL
cells	NULL
.	NULL

Using	NULL
the	NULL
hemocytometer	NULL
,	NULL
cells	NULL
in	NULL
four	NULL
comer	NULL
squares	NULL
(	NULL
total	NULL
64	NULL
small	NULL
squares	NULL
)	NULL
were	NULL
counted	NULL
,	NULL
and	NULL
the	NULL
number	NULL
of	NULL
total	NULL
cells	NULL
was	NULL
calculated	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
adhesion	NULL
was	NULL
defined	NULL
as	NULL
follows	NULL
:	NULL
Adherent	NULL
cells	NULL
Viable	NULL
floating	NULL
cells	NULL
+	NULL
adherent	NULL
cells	NULL
x	NULL
100	NULL
%	NULL
of	NULL
adhesion	NULL
=	NULL
NBT	NULL
Reduction	NULL
Assay	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
0.1	NULL
%	NULL
NBT	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
the	NULL
final	NULL
120	NULL
min	NULL
of	NULL
culture	NULL
,	NULL
then	NULL
the	NULL
floating	NULL
and	NULL
adherent	NULL
cells	NULL
were	NULL
harvested	NULL
separately	NULL
and	NULL
were	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
.	NULL

Cells	NULL
were	NULL
smeared	NULL
on	NULL
glass	NULL
slides	NULL
and	NULL
were	NULL
fixed	NULL
with	NULL
ice-cold	NULL
1	NULL
%	NULL
paraformalde-hyde	NULL
,	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
containing	NULL
intracellular	NULL
blue-black	NULL
formazon	NULL
deposits	NULL
was	NULL
counted	NULL
under	NULL
a	NULL
microscope	NULL
for	NULL
a	NULL
minimum	NULL
of	NULL
200	NULL
cells	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
David	NULL
Hyndman	NULL
for	NULL
designing	NULL
AS	NULL
oligonucleotides	NULL
;	NULL
Steven	NULL
Disper	NULL
for	NULL
synthesis	NULL
of	NULL
oligonucleotides	NULL
;	NULL
Drs	NULL
.	NULL

Shigeo	NULL
Ouno	NULL
,	NULL
Kaoru	NULL
Miyazaki	NULL
,	NULL
and	NULL
Nachiko	NULL
Koshikawa	NULL
for	NULL
their	NULL
helpful	NULL
discussions	NULL
;	NULL
and	NULL
Drs	NULL
.	NULL

Norishi	NULL
Ueda	NULL
and	NULL
Takeshi	NULL
Hayashi	NULL
for	NULL
reviewing	NULL
the	NULL
manuscript	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Bohmann	NULL
,	NULL
D.	NULL
,	NULL
Bos	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Admon	NULL
,	NULL
A.	NULL
,	NULL
Nishimura	NULL
,	NULL
T.	NULL
,	NULL
Vogt	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
Human	NULL
proto-oncogene	NULL
c-jun	NULL
encodes	NULL
a	NULL
DNA	NULL
binding	NULL
protein	NULL
with	NULL
structural	NULL
and	NULL
functional	NULL
properties	NULL
of	NULL
transcription	NULL
factor	NULL
AP-1	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
238	NULL
:	NULL
1386-1392	NULL
,	NULL
1987	NULL
.	NULL

2	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
Allegretto	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Okino	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
Hattori	NULL
,	NULL
K.	NULL
,	NULL
Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
Oncogene	NULL
jun	NULL
encodes	NULL
a	NULL
sequence-specific	NULL
trans-activator	NULL
similar	NULL
to	NULL
AP-1	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
332	NULL
:	NULL
166-171	NULL
,	NULL
1988	NULL
.	NULL

3	NULL
.	NULL

Lee	NULL
,	NULL
W.	NULL
,	NULL
Mitchell	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
Purified	NULL
transcription	NULL
factor	NULL
AP-1	NULL
interacts	NULL
with	NULL
TPA-inducible	NULL
enhancer	NULL
elements	NULL
.	NULL

Cell	NULL
,	NULL
49	NULL
:	NULL
741-752	NULL
,	NULL
1987	NULL
.	NULL

4	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Stein	NULL
,	NULL
B.	NULL
,	NULL
Imbra	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Jonat	NULL
,	NULL
C.	NULL
,	NULL
Herrlich	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
Phorbol	NULL
ester-inducible	NULL
genes	NULL
contain	NULL
a	NULL
common	NULL
cis	NULL
element	NULL
recognized	NULL
by	NULL
a	NULL
TPA-modulated	NULL
transacting	NULL
factor	NULL
.	NULL

Cell	NULL
,	NULL
49	NULL
:	NULL
729-739	NULL
,	NULL
1987	NULL
.	NULL

5	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
Hattori	NULL
,	NULL
K.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
1988	NULL
.	NULL

The	NULL
jun	NULL
proto-oncogene	NULL
is	NULL
positively	NULL
autoregulated	NULL
by	NULL
its	NULL
product	NULL
,	NULL
Jun/AP-1	NULL
.	NULL

Cell	NULL
,	NULL
55	NULL
:	NULL
875-885	NULL
,	NULL
1988	NULL
.	NULL

6	NULL
.	NULL

Ryder	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
Induction	NULL
of	NULL
proto-oncogene	NULL
c-jun	NULL
by	NULL
serum	NULL
growth	NULL
factors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
:	NULL
8464-8467	NULL
,	NULL
1988	NULL
.	NULL

7	NULL
.	NULL

Ryseck	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Hirai	NULL
,	NULL
S.	NULL
I.	NULL
,	NULL
Yaniv	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Bravo	NULL
,	NULL
R.	NULL
Transcriptional	NULL
activation	NULL
of	NULL
c-jun	NULL
during	NULL
the	NULL
G/G	NULL
,	NULL
transition	NULL
in	NULL
mouse	NULL
fibroblasts	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
334	NULL
:	NULL
535-537	NULL
,	NULL
1988	NULL
.	NULL

8	NULL
.	NULL

Ryder	NULL
,	NULL
K.	NULL
,	NULL
Lay	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
A	NULL
gene	NULL
activated	NULL
by	NULL
growth	NULL
factors	NULL
is	NULL
related	NULL
to	NULL
the	NULL
oncogene	NULL
v-jun	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
:	NULL
1487-1491	NULL
,	NULL
1988	NULL
.	NULL

9	NULL
.	NULL

Quantin	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Breathnach	NULL
,	NULL
R.	NULL
Epidermal	NULL
growth	NULL
factor	NULL
stimulates	NULL
transcriptional	NULL
c-jun	NULL
proto-oncogene	NULL
in	NULL
rat	NULL
fibroblasts	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
334	NULL
:	NULL
538-539	NULL
,	NULL
1988	NULL
.	NULL

10	NULL
.	NULL

Brenner	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
O'Hara	NULL
,	NULL
M.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
Chojkier	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Krain	NULL
,	NULL
M.	NULL
Prolonged	NULL
activation	NULL
of	NULL
jun	NULL
and	NULL
collagenase	NULL
genes	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
337	NULL
:	NULL
661-663	NULL
,	NULL
1989	NULL
.	NULL

11	NULL
.	NULL

Wu	NULL
,	NULL
B.	NULL
Y.	NULL
,	NULL
Fodor	NULL
,	NULL
E.	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Edwards	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
and	NULL
Rutter	NULL
,	NULL
W.	NULL
J.	NULL
Nerve	NULL
growth	NULL
factor	NULL
induces	NULL
the	NULL
proto-oncogene	NULL
c-jun	NULL
in	NULL
PC-12	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
264	NULL
:	NULL
9000-9003	NULL
,	NULL
1989	NULL
.	NULL

12	NULL
.	NULL

Pertovaara	NULL
,	NULL
L.	NULL
,	NULL
Sistonen	NULL
,	NULL
L.	NULL
,	NULL
Bos	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Vogt	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
Oja	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
and	NULL
Alitalo	NULL
,	NULL
K.	NULL
Enhanced	NULL
jun	NULL
gene	NULL
expression	NULL
is	NULL
an	NULL
early	NULL
genomic	NULL
response	NULL
to	NULL
transforming	NULL
growth	NULL
factor	NULL
B	NULL
stimulation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
9	NULL
:	NULL
1255-1262	NULL
,	NULL
1989	NULL
.	NULL

13	NULL
.	NULL

Lamph	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
Wamsley	NULL
,	NULL
P.	NULL
,	NULL
Sassone-Corsi	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
|	NULL
.	NULL

M.	NULL
Induction	NULL
of	NULL
proto-oncogene	NULL
JUN/AP-1	NULL
by	NULL
serum	NULL
and	NULL
TPA	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
334	NULL
:	NULL
629-631	NULL
,	NULL
1988	NULL
.	NULL

14	NULL
.	NULL

Lau	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
Expression	NULL
of	NULL
a	NULL
set	NULL
of	NULL
growth-related	NULL
immediate	NULL
early	NULL
genes	NULL
in	NULL
BALB/c	NULL
3T3	NULL
cells	NULL
coordinate	NULL
regulation	NULL
with	NULL
c-fos	NULL
or	NULL
c-myc	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
84	NULL
:	NULL
1182-1186	NULL
,	NULL
1987	NULL
.	NULL

15	NULL
.	NULL

Sheng	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Greenberg	NULL
,	NULL
M.	NULL
E.	NULL
The	NULL
regulation	NULL
and	NULL
function	NULL
of	NULL
c-fos	NULL
and	NULL
other	NULL
immediate	NULL
earty	NULL
genes	NULL
in	NULL
the	NULL
nervous	NULL
system	NULL
.	NULL

Neuron	NULL
,	NULL
4	NULL
:	NULL
477-485	NULL
,	NULL
1990	NULL
.	NULL

16	NULL
.	NULL

Bravo	NULL
,	NULL
R.	NULL
Genes	NULL
induced	NULL
during	NULL
the	NULL
G/G	NULL
,	NULL
transition	NULL
in	NULL
mouse	NULL
fibroblasts	NULL
.	NULL

Semin	NULL
.	NULL

Cancer	NULL
Biol	NULL
.	NULL

,	NULL
1	NULL
:	NULL
37-46	NULL
,	NULL
1990	NULL
.	NULL

17	NULL
.	NULL

Herschman	NULL
,	NULL
H.	NULL
R.	NULL
Primary	NULL
response	NULL
genes	NULL
induced	NULL
by	NULL
growth	NULL
factors	NULL
and	NULL
tumor	NULL
promotors	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
60	NULL
:	NULL
281-319	NULL
,	NULL
1991	NULL
.	NULL

18	NULL
.	NULL

Holt	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Gopal	NULL
,	NULL
T.	NULL
V.	NULL
,	NULL
Moulton	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
and	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
Inducible	NULL
production	NULL
of	NULL
c-fos	NULL
antisense	NULL
RNA	NULL
inhibits	NULL
3T3	NULL
cell	NULL
proliferation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
83	NULL
:	NULL
4794-4798	NULL
,	NULL
1986	NULL
.	NULL

19	NULL
.	NULL

Nishikura	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Murray	NULL
,	NULL
J.	NULL
M.	NULL
Antisense	NULL
RNA	NULL
of	NULL
proto-oncogene	NULL
c-fos	NULL
blocks	NULL
renewed	NULL
growth	NULL
of	NULL
quiescent	NULL
3T3	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
7	NULL
:	NULL
639-649	NULL
,	NULL
1987	NULL
.	NULL

20	NULL
.	NULL

Riabowol	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
Vosatka	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Ziff	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
Lamb	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
and	NULL
Feramisco	NULL
,	NULL
J.	NULL
R.	NULL
Microinjection	NULL
of	NULL
fos-specific	NULL
antibodies	NULL
blocks	NULL
DNA	NULL
synthesis	NULL
in	NULL
fibroblast	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
:	NULL
1670-1676	NULL
,	NULL
1988	NULL
.	NULL

21	NULL
.	NULL

Prochownik	NULL
,	NULL
E.	NULL
V.	NULL
,	NULL
Kukowska	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Rodgers	NULL
,	NULL
C.	NULL
c-myc	NULL
antisense	NULL
transcripts	NULL
accelerate	NULL
differentiation	NULL
and	NULL
inhibit	NULL
G	NULL
,	NULL
progression	NULL
in	NULL
murine	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
:	NULL
3683-3695	NULL
,	NULL
1988	NULL
.	NULL

22	NULL
.	NULL

Holt	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Render	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
An	NULL
oligomer	NULL
complementary	NULL
to	NULL
c-myc	NULL
mRNA	NULL
inhibits	NULL
proliferation	NULL
of	NULL
HL-60	NULL
promyelocytic	NULL
cells	NULL
and	NULL
induces	NULL
differentiation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
:	NULL
963-973	NULL
,	NULL
1988	NULL
.	NULL

23	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Prochownik	NULL
,	NULL
E.	NULL
V.	NULL
Inhibition	NULL
of	NULL
c-jun	NULL
causes	NULL
reversible	NULL
proliferative	NULL
arrest	NULL
and	NULL
withdrawal	NULL
from	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Blood	NULL
,	NULL
79	NULL
:	NULL
2107-2115	NULL
,	NULL
1992	NULL
.	NULL

24	NULL
.	NULL

Schlingensiepen	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
Schlingensiepen	NULL
,	NULL
R.	NULL
,	NULL
Kunst	NULL
,	NULL
M.	NULL
,	NULL
Klinger	NULL
,	NULL
1.	NULL
,	NULL
Gerdes	NULL
,	NULL
W.	NULL
,	NULL
Seifert	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Brysch	NULL
,	NULL
W.	NULL
Opposite	NULL
function	NULL
of	NULL
jun-B	NULL
and	NULL
c-jun	NULL
in	NULL
growth	NULL
regulation	NULL
and	NULL
neuronal	NULL
differentiation	NULL
.	NULL

Dev	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
74	NULL
:	NULL
305-312	NULL
,	NULL
1993	NULL
.	NULL

25	NULL
.	NULL

Sundstrom	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Nilsson	NULL
,	NULL
K.	NULL
Establishment	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
human	NULL
histocytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
(	NULL
U-937	NULL
)	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
17	NULL
;	NULL
565-577	NULL
,	NULL
1976	NULL
.	NULL

26	NULL
.	NULL

Gidlund	NULL
,	NULL
M.	NULL
,	NULL
Om	NULL
,	NULL
A.	NULL
,	NULL
Pattengale	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
Jansson	NULL
,	NULL
M.	NULL
,	NULL
Wigzell	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Nilsson	NULL
,	NULL
K.	NULL
Natural	NULL
killer	NULL
cells	NULL
kill	NULL
tumor	NULL
cells	NULL
at	NULL
a	NULL
given	NULL
stage	NULL
of	NULL
differentiation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
292	NULL
:	NULL
848-850	NULL
,	NULL
1981	NULL
.	NULL

27	NULL
.	NULL

Harris	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Ralph	NULL
,	NULL
P.	NULL
Human	NULL
leukemic	NULL
models	NULL
of	NULL
myelomonocytic	NULL
development	NULL
:	NULL
a	NULL
review	NULL
of	NULL
the	NULL
HL-60	NULL
and	NULL
U937	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

,	NULL
37	NULL
:	NULL
407-422	NULL
,	NULL
1985	NULL
.	NULL

28	NULL
.	NULL

Szabo	NULL
,	NULL
E.	NULL
,	NULL
Preis	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Brown	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
and	NULL
Birrer	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

The	NULL
role	NULL
of	NULL
jun	NULL
and	NULL
fos	NULL
gene	NULL
family	NULL
members	NULL
in	NULL
12-O-tetradecanoylphorbol-13-acetate-induced	NULL
hemopoietic	NULL
differentiation	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

,	NULL
2	NULL
:	NULL
475-482	NULL
,	NULL
1991	NULL
.	NULL

1011	NULL
1012	NULL
-	NULL
Role	NULL
of	NULL
c-jun	NULL
in	NULL
Hematopoietic	NULL
Cell	NULL
Differentiation	NULL
29	NULL
.	NULL

Sherman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Stone	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Datta	NULL
,	NULL
R.	NULL
,	NULL
Bernstein	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
W.	NULL
Transcriptional	NULL
and	NULL
post-transcriptional	NULL
regulation	NULL
of	NULL
c-jun	NULL
expression	NULL
during	NULL
monocytic	NULL
differentiation	NULL
of	NULL
human	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
265	NULL
:	NULL
3320-3323	NULL
,	NULL
1990	NULL
.	NULL

30	NULL
.	NULL

William	NULL
,	NULL
F.	NULL
,	NULL
Wagner	NULL
,	NULL
F.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Kraft	NULL
,	NULL
A.	NULL
S.	NULL
Multiple	NULL
doses	NULL
of	NULL
diacylglycerol	NULL
and	NULL
calcium	NULL
ionophore	NULL
are	NULL
necessary	NULL
to	NULL
activate	NULL
AP-1	NULL
enhancer	NULL
activity	NULL
and	NULL
induce	NULL
markers	NULL
of	NULL
macrophage	NULL
differentiation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
265	NULL
:	NULL
18166-18171	NULL
,	NULL
1990	NULL
.	NULL

31	NULL
.	NULL

Adunyah	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Unlap	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Wagner	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Kraft	NULL
,	NULL
A.	NULL
S.	NULL
Regulation	NULL
of	NULL
c-jun	NULL
expression	NULL
and	NULL
AP-1	NULL
enhancer	NULL
activity	NULL
by	NULL
granulocyte-macroph-age	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
266	NULL
:	NULL
5670-5675	NULL
,	NULL
1991	NULL
.	NULL

32	NULL
.	NULL

Mitsuhashi	NULL
,	NULL
M.	NULL
,	NULL
Cooper	NULL
,	NULL
A.	NULL
,	NULL
Ogura	NULL
,	NULL
M.	NULL
,	NULL
Shinagawa	NULL
,	NULL
T.	NULL
,	NULL
Yano	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Hosokawa	NULL
,	NULL
T.	NULL
Oligonucleotides	NULL
probe	NULL
design	NULL
:	NULL
a	NULL
new	NULL
approach	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
367	NULL
:	NULL
759-761	NULL
,	NULL
1994	NULL
.	NULL

33	NULL
.	NULL

Hyndman	NULL
,	NULL
D.	NULL
,	NULL
Cooper	NULL
,	NULL
A.	NULL
,	NULL
Pruzinsky	NULL
S.	NULL
,	NULL
Coad	NULL
D.	NULL
,	NULL
and	NULL
Mitsuhashi	NULL
,	NULL
M.	NULL
Software	NULL
to	NULL
determine	NULL
optimal	NULL
oligonucleotide	NULL
sequences	NULL
based	NULL
on	NULL
hybridization	NULL
simulation	NULL
data	NULL
.	NULL

Biotechniques	NULL
,	NULL
20	NULL
:	NULL
1090-1097	NULL
,	NULL
1996	NULL
.	NULL

34	NULL
.	NULL

Stein	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Cheng	NULL
,	NULL
Y.	NULL
C.	NULL
Antisense	NULL
oligonucleotides	NULL
as	NULL
therapeutic	NULL
reagents	NULL
:	NULL
is	NULL
the	NULL
bullet	NULL
really	NULL
magical	NULL
?	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
261	NULL
:	NULL
1004-1012	NULL
,	NULL
1993	NULL
.	NULL

35	NULL
.	NULL

Nakabeppu	NULL
,	NULL
Y.	NULL
,	NULL
Ryder	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
three	NULL
murine	NULL
jun	NULL
proteins	NULL
:	NULL
stimulation	NULL
by	NULL
fos	NULL
.	NULL

Cell	NULL
,	NULL
55	NULL
:	NULL
907-915	NULL
,	NULL
1988	NULL
.	NULL

36	NULL
.	NULL

Mitchell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
Transcriptional	NULL
regulation	NULL
in	NULL
mammalian	NULL
cells	NULL
by	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
245	NULL
:	NULL
371-378	NULL
,	NULL
1989	NULL
.	NULL

37	NULL
.	NULL

Ivashkiv	NULL
,	NULL
L.	NULL
B.	NULL
,	NULL
Liou	NULL
,	NULL
H.	NULL
,	NULL
Kara	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Lamph	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
mXBP/CRE-BP2	NULL
and	NULL
c-jun	NULL
form	NULL
a	NULL
complex	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
cyclic	NULL
AMP	NULL
,	NULL
but	NULL
not	NULL
to	NULL
the	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
,	NULL
response	NULL
element	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
:	NULL
1609-1621	NULL
,	NULL
1990	NULL
.	NULL

38	NULL
.	NULL

Hai	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
Cross-family	NULL
dimerization	NULL
of	NULL
transcription	NULL
factors	NULL
Fos/Jun	NULL
and	NULL
ATF/CREB	NULL
alters	NULL
DNA	NULL
binding	NULL
specificity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
:	NULL
3720-3724	NULL
,	NULL
1991	NULL
.	NULL

39	NULL
.	NULL

Ryseck	NULL
,	NULL
R-P.	NULL
,	NULL
and	NULL
Bravo	NULL
,	NULL
R.	NULL
c-JUN	NULL
,	NULL
JUNB	NULL
,	NULL
and	NULL
JUND	NULL
differ	NULL
in	NULL
their	NULL
binding	NULL
affinities	NULL
to	NULL
AP-1	NULL
and	NULL
CRE	NULL
consensus	NULL
sequences	NULL
:	NULL
effect	NULL
of	NULL
FOS	NULL
proteins	NULL
.	NULL

Oncogene	NULL
,	NULL
6	NULL
:	NULL
533-542	NULL
,	NULL
1991	NULL
.	NULL

40	NULL
.	NULL

Chiu	NULL
,	NULL
R.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
Jun-B	NULL
differs	NULL
in	NULL
its	NULL
biological	NULL
properties	NULL
from	NULL
,	NULL
and	NULL
is	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
,	NULL
c-jun	NULL
.	NULL

Cell	NULL
,	NULL
59	NULL
:	NULL
979-986	NULL
,	NULL
1989	NULL
.	NULL

41	NULL
.	NULL

Schiltte	NULL
,	NULL
J.	NULL
,	NULL
Vialiet	NULL
,	NULL
J.	NULL
,	NULL
Nau	NULL
,	NULL
M.	NULL
,	NULL
Segal	NULL
,	NULL
S.	NULL
,	NULL
Fedorko	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Minna	NULL
,	NULL
J.	NULL
Jun-B	NULL
inhibits	NULL
and	NULL
c-fos	NULL
stimulates	NULL
the	NULL
transforming	NULL
and	NULL
trans-activating	NULL
activities	NULL
of	NULL
c-jun	NULL
.	NULL

Cell	NULL
,	NULL
59	NULL
:	NULL
987-997	NULL
,	NULL
1989	NULL
.	NULL

42	NULL
.	NULL

Castellazi	NULL
,	NULL
M.	NULL
,	NULL
Spyrou	NULL
,	NULL
G.	NULL
,	NULL
La	NULL
Vista	NULL
,	NULL
N.	NULL
,	NULL
Dangy	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Piu	NULL
,	NULL
F.	NULL
,	NULL
Yaniv	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Brun	NULL
,	NULL
G.	NULL
Overexpression	NULL
of	NULL
c-jun	NULL
,	NULL
junB	NULL
,	NULL
or	NULL
junD	NULL
affects	NULL
cell	NULL
growth	NULL
differently	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
:	NULL
8890-8894	NULL
,	NULL
1991	NULL
.	NULL

43	NULL
.	NULL

Pfart	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Mechta	NULL
,	NULL
F.	NULL
,	NULL
Spyrou	NULL
,	NULL
G.	NULL
,	NULL
Lallemand	NULL
,	NULL
D.	NULL
,	NULL
Carillo	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Yaniv	NULL
,	NULL
M.	NULL
Mouse	NULL
JunD	NULL
negatively	NULL
regulates	NULL
fibroblast	NULL
growth	NULL
and	NULL
antagonizes	NULL
transformation	NULL
by	NULL
ras	NULL
.	NULL

Cell	NULL
,	NULL
76	NULL
:	NULL
747-760	NULL
,	NULL
1994	NULL
.	NULL

44	NULL
.	NULL

Doucas	NULL
,	NULL
V.	NULL
,	NULL
Spyrou	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Yaniv	NULL
,	NULL
M.	NULL
Unregulated	NULL
expression	NULL
of	NULL
c-jun	NULL
or	NULL
c-fos	NULL
proteins	NULL
but	NULL
not	NULL
JunD	NULL
inhibits	NULL
estrogen	NULL
receptor	NULL
activity	NULL
in	NULL
human	NULL
breast	NULL
cancer	NULL
derived	NULL
cells	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
10	NULL
:	NULL
2237-2245	NULL
,	NULL
1991	NULL
.	NULL

45	NULL
.	NULL

Berko-Flint	NULL
,	NULL
Y.	NULL
,	NULL
Levkowitz	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Vardimon	NULL
,	NULL
L.	NULL
Involvement	NULL
of	NULL
c-Jun	NULL
in	NULL
the	NULL
control	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
transcriptional	NULL
activity	NULL
during	NULL
development	NULL
of	NULL
chicken	NULL
retinal	NULL
tissue	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
13	NULL
;	NULL
646-654	NULL
,	NULL
1994	NULL
.	NULL

46	NULL
.	NULL

Li	NULL
,	NULL
L.	NULL
,	NULL
Chambard	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
and	NULL
Olson	NULL
,	NULL
E.	NULL
N.	NULL
Fos	NULL
and	NULL
Jun	NULL
repress	NULL
transcriptional	NULL
activation	NULL
by	NULL
myogenin	NULL
and	NULL
MyoD	NULL
:	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
Jun	NULL
can	NULL
mediate	NULL
repression	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
6	NULL
:	NULL
676-689	NULL
,	NULL
1992	NULL
.	NULL

47	NULL
.	NULL

Szabo	NULL
,	NULL
E.	NULL
,	NULL
Preis	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
and	NULL
Birrer	NULL
,	NULL
M.	NULL
J.	NULL
Constitutive	NULL
cJun	NULL
expression	NULL
induces	NULL
partial	NULL
macrophage	NULL
differentiation	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

,	NULL
5	NULL
:	NULL
439-446	NULL
,	NULL
1994	NULL
.	NULL

48	NULL
.	NULL

Nishida	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Gotoh	NULL
,	NULL
Y	NULL
.	NULL

The	NULL
MAP	NULL
kinase	NULL
cascade	NULL
is	NULL
essential	NULL
for	NULL
diverse	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

,	NULL
18	NULL
:	NULL
128-131	NULL
,	NULL
1993	NULL
.	NULL

49	NULL
.	NULL

Marshall	NULL
,	NULL
C.	NULL
J.	NULL
MAP	NULL
kinase	NULL
kinase	NULL
kinase	NULL
,	NULL
MAP	NULL
kinase	NULL
kinase	NULL
,	NULL
and	NULL
MAP	NULL
kinase	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

,	NULL
4	NULL
:	NULL
82-89	NULL
,	NULL
1994	NULL
.	NULL

50	NULL
.	NULL

Minden	NULL
,	NULL
A.	NULL
,	NULL
Lin	NULL
,	NULL
A.	NULL
,	NULL
McMahon	NULL
,	NULL
M.	NULL
,	NULL
Lange-Carter	NULL
,	NULL
C.	NULL
,	NULL
Derijard	NULL
,	NULL
B.	NULL
,	NULL
Davis	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Johnson	NULL
,	NULL
G.	NULL
N.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
Differential	NULL
activation	NULL
of	NULL
ERK	NULL
and	NULL
JNK	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
by	NULL
Raf-1	NULL
and	NULL
MEKK	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
266	NULL
:	NULL
1719-1723	NULL
,	NULL
1994	NULL
.	NULL

51	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
Jacinto	NULL
,	NULL
E.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Kallunki	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Ben-Neriah	NULL
,	NULL
Y.	NULL
JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
T	NULL
lympho-cytes	NULL
.	NULL

Cell	NULL
,	NULL
77	NULL
:	NULL
727-736	NULL
,	NULL
1994	NULL
.	NULL

52	NULL
.	NULL

Marshall	NULL
,	NULL
C.	NULL
J.	NULL
Specificity	NULL
of	NULL
receptor	NULL
tyrosine	NULL
kinase	NULL
signaling	NULL
:	NULL
transient	NULL
versus	NULL
sustained	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
activation	NULL
.	NULL

Cell	NULL
,	NULL
80	NULL
:	NULL
179-185	NULL
,	NULL
1995	NULL
.	NULL

53	NULL
.	NULL

Cowley	NULL
,	NULL
S.	NULL
,	NULL
Paterson	NULL
,	NULL
H.	NULL
,	NULL
Kemp	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Marshall	NULL
,	NULL
C.	NULL
J.	NULL
Activation	NULL
of	NULL
MAP	NULL
kinase	NULL
kinase	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
PC12	NULL
differentiation	NULL
and	NULL
for	NULL
transformation	NULL
of	NULL
NIH	NULL
3T3	NULL
cells	NULL
.	NULL

Cell	NULL
,	NULL
77	NULL
:	NULL
841-852	NULL
,	NULL
1994	NULL
.	NULL

